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Abstract 
 
Cyclic amino acids (imino acids) were synthesized from intramolecular cyclization of amino 
acids functionalized with side chain epoxides; The allyl glycine and homo allyl glycine 
derivatives were obtained from the diethyl 2-aminomalonate derivatives, in a series of 
reaction which finally gave a racemic mixture of allyl glycine/homo allyl glycine. These 
racemic mixture were well resolved and separated by one of these commercially available 
enzymes, L-acylase, -chymotrypsin and subtilisin Carlsberg. The epoxides were obtained by 
epoxidation of the side chain of enatiomerically pure 2-amino-4-pentenoic acid and its higher 
homologue 2-amino-5-hexenoic acid (homo allyl glycine). The epoxides were then 
intramolecularly cyclized to form 4-hydroxyproline from epoxide of allyl glycine or  
5-hydroxypipecolic acid from epoxide of homo allyl glycine. 
 The enatiomers of allyl glycine were separated by effective resolution aided by 
subtilisin Carlsberg or L-acylase. The enatiomerically pure allyl glycine derivatives with 
(Boc) protection were epoxidized with m-CPBA which generated the inseparable 
diastereomeric epoxide. Upon removal of the Boc protection generated highly nucleophilic 
amine which attacked the side-chain epoxide intramolecularly at the C5 carbon generating 4-
hydroxyproline derivatives. Due to presence of 2 chiral centers formed during the 
epoxidation trans- and cis- isomers of 4-hydroxyprolines are formed. Fortunately the cis- 
isomer was transformed to a lactone with the removal of alcohol. The cis-conformation of the 
hydroxyl and ester was necessary for the intramolecular reaction; the trans- isomer remained 
as such without lactone formation. Due to the selective intramolecular lactonization of the 
cis- isomer into an hydrophobic lactone, the separation of the lactone from the hydrophilic 
trans- isomer was facile and easy. Similarly starting from the D- isomers two diastereomers 
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of 4-hydroxyproline were synthesized.  
 Similarly racemic mixture of 2-amino-5-hexenoic acid were synthesized from diethyl 
malonate derivatives. This racemic mixture of 2-amino-5-hexenoic acid was separated by 
resolution aided by L-acylase or -chymotrypsin. The separated enatiomerically pure amino 
acids with tert-butoxycarbonyl (Boc) protection were oxidized with excess amount of 3-
chloroperbenzoic acid (m-CPBA). The oxidation by m-CPBA generates two inseparable 
diastereomeric epoxides which are formed due to new chiral center at C5 carbon. One of the 
diastereomeric epoxide in the inseparable mixture was selectively converted to a dihydroxyl 
compound catalyzed by Jacobsen's hydrolytic kinetic resolution (HKR) which was easily 
separated from the remaining diastereomeric epoxide. The epoxide was converted to a vicinal 
halohydrin, with bromide attacking on terminal C6 carbon. Upon (Boc) deprotection of the 
halohydrin, the free amine attacked the C6 carbon, generating 5-hydroxypipecolic acid which 
was isolated in good yield after protection of the amine with (Boc) group. In a similar manner 
the dihydroxyl component which was converted to an halohydrin by efficient regioselective 
mono-tosylation with catalytic (Bu2SnO) followed tosyl replacment by iodine substitution. 
The halohydrin was used to synthesize 5-hydroxypipecolic acid derivative by Boc removal 
with acid treatment, intramolecular cyclization, N- reprotection and isolation. The same 
sequence was repeated for D- isomers. 
 Finally racemic mixture of 2-amino-5-hexenoic acid were prepared by the same 
sequence described above. This racemates were subjected to subtilisin carlsberg based 
resolution, which gave chiraly pure 2-amino-5-hexenoic acid. The alkene side chain of the 
fully protected amino acids were oxidized with m-CPBA, which gave the diastereomers, 
which were not separable. On treating the epoxide with acid led to the removal of N-Boc 
group and formation of the free amine. This amine was allowed to attack the epoxide, by 
treating the amine with base, which led to the neutralization of the acid. The amine 
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regioselective attacked the C6 carbon to generate the 5-hydroxypipecolic acid derivatives. 
The amine was again reprotected with Boc2O to generate the fully protected 5-hydroxy 
pipecolic acid derivatives Due to the diastereomeric nature of the starting material, two 
product were formed (cis-) and (trans)-5-hydroxypipecolic acid. But in our reaction 
conditions the cis- isomer due to the close proximity of the hydroxyl and ester group 
underwent  in-situ lactonization to form the hydrophobic lactone. The lactone was easily 
isolated from the trans- ester. Similarly starting from the L- isomer two isomers of 5-
hydroxypipecolic acid were obtained. 
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Chapter 1 
 
Introduction 
 
1. Overview of -amino acids 
 
The -alpha amino acids are the building blocks for the proteins which is one of the 
important bio-macromolecule. -amino acids  are so called, because they have an amino 
group attached to the  carbon of a carboxylic acid. There are more than 700 -alpha amino 
acid known today when the counting was discontinued in 1985.1-3 Formally only 20 amino 
acids in this group is called the proteinogenic amino acids which are encoded by the codons 
to form the proteins/peptides.4  Further these proteinogenic amino acids are broadly classified 
into essential and non essential amino acids. The essential amino acids are one which are 
required by the organisms in their diet and they cannot synthesize within the body, where as 
non-essential amino acids need not be taken in diet and can be synthesized within the body of 
the organisms.5 For example Proline (Pro) is an non-essential amino acid which is 
synthesized from glutamic acid in three steps via an enzyme catalyzed reactions. Glutamate is 
phosphorylated on the gamma carbonyl to yield glutamyl phosphate. The glutamyl phosphate 
is reduced to glutamyl semialdehyde which cyclized to form pyrrolidiene carboxylate, which 
is reduced to proline in the final step.6 
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Scheme 1) Biosynthesis of proline. 
 
2. Proline 
 
The cyclic imino acid structure of proline (Pro) is exceptional in the natural amino acids that 
are found in proteins. Proline residue is not usually included in the α-helix and β-sheet  
structures in proteins, but regulates the molecular structure of peptide secondary structure.7 
Of the 20 proteinogenic amino acids, Proline is the only cyclic amino acid (Figure 1. 1.7). 
 
 
 
 
 
Figure 1)  1.6 General structure of 19 proteinogenic amino acids; 1.7 Proline 
 
While all the 19 amino acids have their R group (R= H, Me, Bn.....) attached to alpha carbon 
free, it is not the case in proline. In proline the alpha carbon is reattached to the nitrogen and 
forms a ring. This gives the proline carbon rigidity due to the cyclic structure. But in the 
proteins after the peptide bond is formed the proline cannot participate in the hydrogen bond 
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formation due its secondary amine group. Further when two amino acids form a peptide bond, 
the resulting bond has an appreciable double bond character (~40%). The trans conformation 
is favored for peptide bonds that do not involve cyclic proline (99.9%) where as cis content is 
as low as (0.1%).8-9 But when a peptide bond is formed with proline, i.e., (Xaa-Pro), where 
Xaa represents any amino acids, cis- content close to 10-30% are found.10-12 
 
 
3. 4-Hydroxyproline. 
 
4-Hydroxyprolines (Hyp) exist naturally as a modified amino acids with an hydroxyl group at 
the 4th position of the proline ring. The 4-hydroxyproline has two chiral centers, thereby they 
have totally four stereoisomers (1.8-1.11, Figure 2) 
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Figure 2) Stereoisomers of 4-hydroxyproline. 
 
  L-trans-4-hydroxyproline (2S,4R- isomer, 1.8) is mainly found in collagen, and is 
responsible for its stabilization. Collagen is a made up of three polypeptide strands, which 
folds into a right-handed triple helix.13 Each individual strands have around 300 repeating 
monomer of (X-Y-Gly) folded in to polyproline-II helix.14  Proline residues with-in the 
collagen triple helix is hydroxylated to form the 4-hydroxyproline (1.8), this post-
translational modification is most common within the human body. This hydroxylation is 
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highly stereoselective which give rise to only 1.8 (Figure 2).15-16 It is mainly found in the Yaa 
position, whereas (2S)-proline (1.7, Figure 1) is found in Xaa position.17 
 4-hydroxyproline as a derivative is found in MK-1220, which is a very potent 
Hepatitis C Virus NS3/4A protease inhibitor.18 Furthermore 4-hydroxyproline is found in 
Microlin A which have anti proliferative and immunosuppressive activity. Microlin A has 
been shown to inhibit human two-way mixed lymphocyte response which inhibit the 
suppressive immune system against organ transplantation.19-20 In addition trans-
hydroxyproline is used in cosmetic products.   
 N-acetyl trans-4-hydroxyproline a common derivative of 4-hydroxyproline which is 
commonly referred to as oxaceprol (1.12, Figure 3) is an inhibitor of inflammation and used 
for treating osteoarthritis.21 cis-4-hydroxyproline (1.13, Figure 3) acts as an anticancer drug, 
as it prevents excessive deposition of collagen in fibrotic processes and the growth of 
tumors.22-24 The application and study of cis-4-hydroxyproline, (1.13) has been reinforced 
due to its ability to inhibit proliferation of Panc02 tumor cells in both in vitro and in vivo.25 4-
Hydroxyproline derivatives have been used extensively in preparing 4-fluroproline 
derivatives (1.14) which drastically enhance the conformational stability of the proteins.26 
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Figure 3) 
Due to its above mentioned significance several synthesis of 4-hydroxyproline have been 
attempted with considerable success. trans-4-hydroxy-L-proline (1.8) was synthesized as 
outlined in (Scheme 2) compound 1.15 was easily alkylated with allyl bromide in presence of 
base LDA and n-BuLi which gave the allylated derivative 1.16, which gave the only 
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stereoisomer in 90% yield. Subsequently (1.16) was treated with I2 in aqueous THF, which 
gave the bicyclic compound 1.17 (75%), as the only product. Finally acidic hydrolysis of the 
bicyclic compound provided 1.8 in quantitative yield.27  
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Scheme 2) Synthesis of 1.8 
 In order to obtain the cis-4-hydroxyproline, commercially available (-)-menthyl ester 
of hippuric acid 1.18, was treated with allyl iodide in the presence of  base LiHMDS (2 eq) in 
THF which resulted in (2 :1 mixture of diastereoisomers). This product was recrystallized 
from EtOAc, and the mother liquor was purified (SiO2) to obtain 1.19 (53%). Cyclization in 
same condition as above, with I2 in aqueous THF, gave 1.20 (72%), which was separated by 
(SiO2). Finally acidic hydrolysis in a sealed tube  provided cis-4-hydroxy-L-proline 1.9 in 
quantitative yield (Scheme 3).27 
Gomez-Vidal et al.28 reported the synthesis of 4-hydroxyproline from the trans-4-
hydroxyproline derivative (1.21, Scheme 4). Starting from N-carbamate (Boc) derivative the 
free acid was converted into a bicyclic lactone with the aid of Mitsunobu  reaction (1.22). 
Subsequently the lactone was converted into the fully protected cis-4-hydroxyproline 
derivative (1.23), in methanol in presence of sodium azide. Similarly there are several reports 
that employ this mitsunobu reaction to synthesize cis-4-hydroxyproline.  
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Scheme 3) Synthesis of 1.9 
A very similar approach to cis-4-hydroxyproline involves the involves the inversion of the C4 
hydroxyl group of the trans-4-hydroxyproline derivative. In this reaction the first step 
involved the activation of the hydroxy group as a tosylate/mesylate and followed by internal 
displacement of the tosylate/mesylate by the free carboxylic acid to form the bicyclic 
lactone.29-30 
 
  
N
Boc
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Boc
CO2MeN
Boc
CO2H
HO HO
1.21                                                1.22                                               1.23
O
O
DEAD, Ph3P
THF, 82%
NaN3
MeOH,
100%
 
 
Scheme 4) Synthesis of cis-4-hydroxproline by Mitsunobu reaction. 
 A green and environmentally suitable synthesis of  4-hydroxyproline has also been 
attempted with the aid of bacterial enzymes cis-4- and trans-4-proline hydroxylase (cis-P4H 
or trans-P4H).31 
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Scheme 5) Bicyclic ring synthesis by intramolecular reaction. 
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Scheme 6) Proline-4-hydroxylase catalyzed synthesis of 4-hydroxyproline. 
 
4.  5-hydroxypipecolic acid 
5-Hydroxypipecolic acid (5-hydroxypiperidine-2-carboxylic acid) is an higher homologue of 
4-hydroxyproline, discussed in the previous section. 5-hydroxypipecolic acid is an important 
cyclic imino acid  found in found in plants32-33 and animals34 where it occurs as a metabolic 
by-product. Similar to 4-hydroxyproline these 5-hydroxypipecolic acid contains two chiral 
centers, as a results it has totally four stereoisomers (Figure 5). 
 
N
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CO2H N
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H H H H
1.26                 1.27                   1.28                 1.29  
 
Figure 5) Four stereoisomers of 5-hydroxypipecolic acid.  
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 Derivative of 5-hydroxypipecolic hydroxamic acid (1.30, Figure 6) acts as a very 
potent inhibitor of TNF- converting enzyme (TACE), that produces TNF- which is 
responsible for pain and cartilage breakdown in people suffering from Crohn's disease(CD) 
and rheumatoid arthritis (RA).35-36 
 
N
N
OO3SO
O
N
NH2
1.31
H
OCH2Ar
1.30
N
HO
CO2H
 
 
Figure 6. Derivatives of 5-hydroxypipecolic acid. 
 
 Very recently cis-5-hydroxypipecolic acid (1.26, Figure 5) was used as a starting 
material for the synthesis of β-lactamases inhibitor MK-765537 (1.31, Figure 6), which  when 
administered in combination with Merck’s Primaxin® is presently in phase II clinical trials for 
the treatment of gram-negative bacterial infections.38 5-hydroxypipecolic acid is also 
employed in the synthesis of 5-guanidino pipecolates (1.32, Figure 7) which acted as 
constrained arginine mimetic and exhibited weak to moderate inhibition of nitric oxide 
synthase (NOS), which are needed to inhibit production of excessive NO which lead to 
central nervous system disorders.39 cis-5-hydroxypipecolic acid demonstrates  inhibition of 
Aspergillus spp responsible for spoilage of stored grains.40 It  is also reported to display 
potent inhibitory effects on human platelet aggregation induced by serotonin.41 
Due to its above mentioned importance several groups have attempted the synthesis of 5-
hydroxypipecolic acid.42-46 trans-5-hydroxypipecolic acid was synthesized as shown in 
(scheme 7). The reaction was started with commercially available (1.33) by N protection 
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Figure 7 
 followed by esterification with MeI to obtain the protected amino acid 1.34. Which was 
cyclized to 1.35 in the presence of catalytic (TsOH) in good yield. Next epoxidation of 
enamide 1.35, in MeOH led to ring-opening of epoxide intermediate to form 1.36. Oxone® 
gave the good results for epoxidation, with a excellent diastereoselectivity for the (2S,5R)-
configured product. Finally hydrogenation, followed by hydrolysis gave 1.27 as HCl salt 
which was isolated by crystallization, with 87% overall yield. 
(Bailey & Bryans)14 achieved the synthesis of 5-hydroxypipecolic acid starting from the 
commercially available glutamic acid  derivative 1.37. Protection of -acid was successful by 
selective oxazolidinone  formation followed by methanolysis to give 1.39. The remaining 
acid was transformed to a mixed anhydride 1.40, by reacting with ethyl chloroformate under  
O
O
H2N CO2H
O
O
CbzHN CO2Me
N CO2Me
Cbz
N CO2Me
Cbz
HO
MeO N CO2H
H
HO
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    NaHCO3
2) MeI, K2CO3
TsOH
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toluene, 
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Oxone
NaHCO3
MeOH
1) Pd/C, H2
2) 6M HCl
1.33 1.34 1.35
1.36 1.27  
 
Scheme 7) Synthesis of 5-hydroxypipecolic acid from commercially available L-allylsine 
ethylene acetal (1.33).1 
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basic condition which was followed by treatment with diazomethane to yield the diazoketone 
1.41, which was converted into the chloroketone 1.42 with HCl in Et2O in 60% overall yield 
from 1.37. After failure to cyclize the piperidine ring system at this stage, possibly due to 
carbonyl group, cyclization was achieved after reduction of carbonyl to a diastereomeric 
mixture (1:l) 1.43. Protection of the hydroxyl with TBDMS-Cl and cyclization in DMF at 60 
C in the presence of NaH as base yielded pipecolic acid derivative 1.45 in 60% yield. 
Deprotection of the silyl group with HF gave an inseparable mixture 1.46. Finally refluxing 
this mixture in benzene with catalytic p-TsOH gave two separable components, identified as 
the lactone 1.48 and the trans ester 1.47. 
Finally direct enzymatic hydroxylation of the rigid pipecolic acid to generate the 5-
hydroxypipecolic acid as also been tried with considerable success. This direct hydroxylation 
with enzymes is important since it transforms the non oxygenated compound to oxygenated 
compound by using milder condition thereby avoiding the use of complex oxidising agent.   
Efficient synthetic production of 5-hydroxypipecolic acid have been achieved by enzymatic  
hydroxylation of L-pipecolic acid with the aid of trans-4-proline-hydroxylase.47-50 
5. Conclusion 
In summary, cyclic amino acids are an important class of amino acids. Of the various 
derivatives found in nature, 4-hydroxyproline and 5-hydroxypipecolic acid are two examples. 
These proline and pipecolic acid derivatives are found in many of the pharmaceutically and 
medicinally important compounds. Additionally they are present in many important proteins, 
ex. Collagen. When they are present within the proteins they give them additional stability 
and rigidity. 
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Scheme 8) Synthesis of 5-hydroxypipecolic acid from commercially available L-glutamic acid 
derivative (12).14 
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Scheme 9. Synthesis of 5-hydroxypipecolic acid by hydroxylation of L-pipecolic acid 
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 6. Organization of the present thesis. 
 
This thesis explores and demonstrates the utilization of epoxy amino acids for synthesis of 
cylic amino acids. We explored our methodology for synthesis of two amino acids, 4-
hydroxyproline and 5-hydroxypipecolic acid, by combination of both enzymatic and organic 
synthesis. 
 First chapter describes the importance of cyclic amino acids and relevance of this 
cyclic amino acids. Followed by the important synthetic procedure for this cyclic amino acids.  
 Second chapter deals with the details of instruments, techniques and characterization 
methods used. 
 Third chapter describes the synthesis of four stereoisomers of 4-hydroxyproline, by 
using a combination of both enzymatic and organic synthesis. 
 Fourth chapter elaborates the synthesis of four stereoisomers of 5-hydroxypipecolic. 
In this, both enzymatic and hydrolytic kinetic resolution was used to provide an easy access 
to all the isomers of 5-hydroxypipecolic acid in good yield. 
 Fifth chapter deals with regioselective cyclization of the epoxy amino acids and in-
situ lactonization to generate the 5-hydroxypipecolic acid isomers. This study explores the 
use of enzyme subtilisin Carlsberg for the resolution of the racemic amino acids. 
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Chapter 2 
 
Instrumentation 
 
1. Nuclear magnetic resonance spectroscopy 
 
Nuclear magnetic resonance (NMR) spectroscopy is dominantly employed in characterization 
of organic materials.1 NMR is based on magnetic interactions of the nuclei with the external 
applied magnetic field.2 Upon application of external magnetic field the spin of nuclei which 
is disoriented otherwise gets aligned. In NMR spectroscopy electromagnetic radiation is used 
to excite this oriented spin in presence of external magnetic field to a higher energy state 
resulting in induction of output radio signal which is detected and processed. The chemical 
shift is specific to a particular nuclei and correlates its chemical environment. NMR is 
employed to detect various isotopes of a nuclei, such as 1H NMR for hydrogen, 13C NMR for 
carbon, 31P NMR for phosphorus and so on. The 13C NMR is less sensitive than proton NMR, 
since the 13C is only 1% of the total carbon content on earth.3  
        In the present study 1H NMR and 13C NMR were utilized to characterize and determine 
the chemical structure of the various compounds synthesized. 1H NMR spectrum was 
recorded at 500 MHz, 13C NMR spectrum was recorded at 125 MHz. TMS was used an 
internal reference with chemical shift value 0 ppm for all the samples. The compounds were 
dissolved in appropriate deutereated solvents and NMR was performed. The chemical shift 
values are given in ppm (parts per million). 
28 
 
2. Fast atom bombardment ionization mass spectrometer 
 
 Mass spectroscopy is used to identify materials by determining of mass of the free ions in 
high vacuum.4  The mass spectrum gives a plot of ion signal versus mass to charge ratio and 
enables to determine the mass to charge ratio and gas phase ions abundance.5 In mass 
spectrometer analysis the target sample is ionized and these ions are segregated according to 
their mass to charge ratio by mass analyzer and mass spectrum is delivered by the detector. 
Various types of mass spectrometers are available in the market. One of the critical variations 
among the mass spectrometers is the method of ionization. Samples can be ionized by 
bombarding the sample with high energy source beam of atoms or ions (FAB),6 by electron 
impact, or by photons (Laser desorption/Ionization).  
                 FAB is a soft ionization technique producing deprotonated or protonated species 
and was developed by Michael Barber, University of Manchester.7-8 The material is mixed 
with a matrix and subjected to bombardment by high energy beam of atoms generally from 
an inert gas such as xenon or argon. Two most commonly used matrix are glycerol and m-
nitro benzyl alcohol.  
                                         
O2N
OH
                                                         OH
OH
OH  
                                             a                                                                  b 
Figure 2.1) Common used matrixes for Fab mass a) m-nitro benzyl alcohol and b) glycerol 
               In the current study the various compounds synthesized were characterized by the 
FAB mass spectrometer by mixing with matrix m-nitro benzyl alcohol.   
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3. Single crystal X-ray diffractometer (XRD) 
 
 Single crystal XRD is technique employed for deriving information about the crystal lattice 
of the crystalline material and analyze the molecular structure. It provides details about the 
crystal dimensions such as bond lengths, unit cell dimensions and bond angles.9 It is 
nondestructive technique as the sample properties are retained and includes an X-ray source. 
The diffracted X-ray angles and intensity from the sample are dependent on the nature of the 
material, hence are detected and analyzed to obtain the crystal structure.  X-ray diffraction 
constructive interference occur when the X-rays of the sample interaction with the incident 
X-rays satisfy Bragg’s law.10 
Bragg's equation:  nλ=2d sinθ (1) 
      Where n is a positive integer, λ is incident light wavelength, θ is scattering angle and d is 
interplanar distance. The diffraction angle, wavelength and crystal spacing can be obtained by 
utilizing the Bragg's law.  
          An unfractured clear optical crystals of the sample are required for application of single 
crystal XRD study to derive the crystal structure of the material. Therefore single crystals 
were grown in the current study by using appropriate solvents. A highly concentrated sample 
solution was made by dissolving the compound in the appropriate solvent in which it is 
soluble. Little amount of this solution is transferred into a small vial which was half 
immersed in a closed container containing an insoluble solvent and the set up was tightly 
packed and left undisturbed.  The insoluble solvent slowly diffuses into the sample solution 
over a period of time resulting in crystals. The single crystals thus obtained were picked with 
needle, polished and subjected to XRD. 
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4. High performance liquid chromatography (HPLC) 
 
HPLC is an analytical tool utilized in separation of liquid mixtures.11 It consists of a 
pressurized sample inlet, column (stationary phase), pump for transmitting solvents (mobile 
phase) and a detector.12 The sample is injected and passed through the column. The 
components of a liquid mixture are separated based on their difference in interaction with the 
stationary phase which results in different flow rates for individual components.13 The 
transport of the components of the mixture is facilitated by the mobile phase. The interactions 
of the sample with the column is defined by the adsorbent material of the column. The 
components are separated based on difference in adsorption if the column is alumina or 
silica,14 ion exchange if column is a solids functionalized with sulfonic acid,15 size-exclusion 
if the column is a porous silica or polymeric particles.   
Chiral HPLC was used for the analysis of enatiomeric excess (ee).16 Wherein, the racemic 
mixture identified by HPLC is taken as reference. After the resolution of the amino acids each 
enatiomer is modified similar to reference and the enatiomeric excess is determined by using 
the same conditions and solvents as that of the reference. The purity of products were also by 
checked by the HPLC.17 
 
5. Polarimeter 
 
Polarimetry is a nondestructive technique utilized for measuring the optical activity of the 
molecule.18 When linear polarized light is passed through the optically active molecule. The 
polarized light is rotated eight clockwise or anticlockwise. The amount of rotation called 
angle of rotation is dependent on the concentration of the chiral molecules. Polarimetry is 
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used to analyze the optical purity, ratio and the concentration of two enantiomers of a 
molecule.19 Optical activity is determined by several factors such as temperature, length of 
the sample tube or cell, concentration of the sample and wavelength of the light passing 
through the sample. Specific rotation20 is defined as optical rotation at path length of 1 dm, 
concentration of 1g/100 ml, light wavelength typically sodium D line (589.3 nm) at room 
temperature (20 0C).  
Specific rotation: 𝛂𝛌 
𝑻  =  𝟏𝟎𝟎. 𝛂 𝒍. 𝑪⁄       (2) 
αλ 
𝑇  = specific rotation 
T = temperature, 
λ = wavelength, α = optical rotation, 
c = concentration in g/100ml, l = optical path length in dm. 
Equation 2 can be used to calculate the concentration of the pure substance by fixing the 
wavelength of the polarized light and path length. Thus the amount of enatiomers in a given 
sample can be determined employing polarimetry.21 
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Chapter 3 
 
Intramolecular Cyclization of Epoxy Amino Acids 
Produced from Allylglycines to Prepare Four 
Stereoisomers of 4-Hydroxyproline Derivatives1a 
 
1. Introduction 
 
4-hydroxyproline (4-Hyp) is mainly found in collagen.1b Hyp is also found in antifungal 
peptides,2 immunosuppressive natural product, microcolin A,3 anticancer drugs,4,5 The 
conformation of 4-hydroxyproline's five-membered ring has been elucidated recently.6 
Furthermore, non-natural hydroxyprolines have been incorporated into a synthetic antagonist 
of a histamine H3 receptor7 and a diverse artificial polypeptide library.8 
 Various methods have been proposed for the synthesis of 4-hydroxyprolines including 
Mitsunobu conditions3,9-12 and other reactions7,13,14 which gave L-cisHyp. Also been 
elaborated by using chiral compounds.15,16 and biological methods.5,17,18  
 
N
H
CO2H
HO
N
H
CO2H
HO
N
H
CO2H
HO
N
H
CO2H
HO
3.1 3.2 3.3 3.4  
Figure 1) 4-hydroxyproline stereoisomers 
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 But these synthesis have serious limitation. 4-Hydroxyproline (3.1) is mainly 
synthesized by acidic hydrolysis of collagen. However, this process includes a complex 
purification procedure, extractive process and removal of toxic solvents.19  Of the four 
possible derivatives of 4-hydroxyprolines (3.1-3.4), most synthetic procedures describe the 
synthesis of only one stereoisomer. The cis- isomer (3.2) is mainly obtained from the trans- 
isomer, by Mitsunobu reaction, but despite these advances there is a difficulty in removing 
the Mitsunobu by-products. Moreover this procedure requires the use of DEAD which is 
documented to be both toxic and explosive.20 Similarly the synthesis of 4-hydroxyproline by 
intramolecular displacement of the tosyl/mesylate by the carboxyl generated the cis- 
derivatives with a moderate/very low yield. The bacterial synthesis has a serious drawback of 
non-availability of the enzymes commercially. Additionally the bacterial synthesis need 
specialized equipments to carry out the process. The products generated by bacterial synthesis 
are water soluble and need to be purified twice and reprotection of the amine or carboxyl is 
necessary before being applicable to solid phase peptide synthesis (SPPS) or solution phase 
synthesis. Moreover the yields in this reaction were also low. Hence in this protocol the 
proposed method yield all the four diastereomers starting from a common intermediate. The 
cis- and trans- isomers were easily separated by simple silica gel column chromatography, 
due to the intramolecular lactonization.  
 
2. Results and discussion 
 
 Enzymatic Resolutions of 2-Amino-4-Pentenoic Acid (Allylglycine) Derivatives as 
Starting Materials.  
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EtOOC COOEt
NH
BocNH COOEt
(RS)-3.6
Subtilisin
H2O (pH 8.0)
-DMF (3:1)
BocNH COOH
(S)-3.7
BocNH COOEt
(R)-3.6
+
Boc
3.5  
 
Scheme 1) Enzymatic Synthesis of 2-Amino-4-Pentenoic Acid Derivatives 
 
The racemic mixture of 2-amino-4-pentenoic acid (DL-allylglycine) derivatives were 
obtained from malonate derivatives and subjected to enzymatic resolution. Two enzymes 
were tested for the resoltuion, subtilisin carlsberg for amino acid esters and L-acylase for 
acetyl amino acid. (Scheme 1). 
 The racemic mixture of ethyl 2-Boc-amino-4-pentenoate (3.6, Boc = tert-
butoxycarbonyl) was synthesized from diethyl (2-Boc-amino)malonate (3.5). Initially the 
malonate was treated with excess allyl bromide in refluxing EtOH in the presence of NaOEt. 
This gave rise to allylated malonate diester, which was subsequently half saponified with 
base and then decarboxylated by refluxing in toluene which generated the racemic 3.6 (91% 
yield in three steps based on diethyl (2-Boc-amino)malonate). 
 Subsequently 3.6 was suspended in a mixture of H2O–DMF (3:1, v/v) and hydrolyzed 
with enzyme Subtilisin while maintaining the pH at 8.0 (aqueous NH3) and while maintaining 
the temperature at 40 oC. After 3 h the unreacted ester (R)-3.6 was at first extracted into the 
organic layer at alkaline aqueous solution. The alkaline solution was then acidified to pH~3 
with solid citric acid and (S)-2-Boc-amino-4-pentenoic acid ((S)-3.7) was extracted into 
EtOAc. The yields of (R)-3.6 and (S)-3.7 were approximately 48%. The chemical and 
enantiomeric purities of (S)-3.7 and (R)-3.6 (after deprotection) were ascertained by 1H NMR, 
chiral HPLC, and the specific rotation measurements.21-23 Thus, (S)-3.7 and (R)-3.7 were 
successfully obtained from racemic 3.6 by kinetic enzymatic resolution. 
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EtOOC COOEt
NH
AcNH COOH
(RS)-3.9
acylase
H2O (pH 7.0)
H2N COOH
(S)-3.10
AcNH COOH
(R)-3.9
+
Ac
3.8  
 
Scheme 2. Enzymatic synthesis of 2-amino-4-pentenoic acid 
 
   Next, diethyl acetamidomalonate (3.8), which is less expensive than diethyl (2-Boc-
amino)malonate (3.5), was selected as a starting material. Similar to diethyl (2-Boc-
amino)malonate, diethyl acetamidomalonate was reacted with allyl bromide, half saponified, 
decarboxylated in refluxing toluene, and then subjected to second saponification affording 
racemic 2-acetamido-4-pentenoic acid (3.9, 37% yield in four steps based on diethyl 
acetamidomalonate, 3.8) (Scheme 2). 
 This racemic acetyl amino acid 3.9 was treated with acylase under pH 7.0 (aqueous 
LiOH) conditions with Co2+ at 37 oC.24-26 After 24 h, the solution was acidified and extracted 
with EtOAc to afford unreacted (R)-3.9, which was purified by silica gel column 
chromatography to yield a brown semi-solid compound. The remaining acidic solution was 
subjected to the ion-exchange resin (-SO3H type), and product (S)-2-amino-4-pentenoic acid 
((S)-3.10) was obtained as a white solid when the resin was washed with aqueous NH3. In 
these procedures, products 3.10 and 3.9 were highly water soluble, and their isolations were 
not simple. The isolated amounts of (R)-3.9 and (S)-3.10 were not high (28% and 22%, 
respectively, based on diethyl acetamidomalonate). However, these procedures (i.e., kinetic 
enzymatic resolution using acylase) also, the chemically and enantiomerically pure (S)-3.10 
and (R)-3.10 (obtained from (R)-3.9)27 were produced, which were analyzed by 1H NMR and 
chiral HPLC. 
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Epoxidation of Amino Acid Derivatives with Unsaturated Side Chains. 
BocNH COOR
-R = -H; (S)-3.7
-R = -CH2Ph; (S)-3.11
BocNH COOCH2Ph
(2S,4S)-3.12
+
m-CPBA
DCM BocNH COOCH2Ph
O O
(2S,4R)-3.12
(57:43)
2
3 4
5
 
Scheme 3) Epoxidation of Side Chain C=C Bond of Benzyl (S)-2-Boc-amino-4-pentenoate  
   
 Kinetically resolved Boc-amino acid (S)-3.7 was esterified with benzyl bromide using 
Et3N to afford benzyl (S)-2-Boc-amino-4-pentenoate ((S)-3.11) in 64% yield. This Boc-amino 
acid ester with an unsaturated side chain was epoxidized with excess m-chloroperbenzoic 
acid (m-CPBA) in CH2Cl2.28-30 The reaction was nearly completed after 24 h at room 
temperature (TLC), and the excess m-CPBA was subsequently reduced with Na2SO3. After 
being washed and chromatographically purified over silica gel (hexane–15% EtOAc), Boc-
amino acid benzyl esters with side-chain epoxy groups, benzyl (2S)-2-Boc-amino-3-(2-
oxiranyl)propionate isomers ((2S)-3.12) were obtained in 69% yield (Scheme 2).31,32 
  
 
 
 
 
 
 
 
Figure 2. 1H NMR (1D and 2D-COSY) spectra of (2S)-3.12 in CDCl3 (high-field region). See 
Scheme 2 for C3H, C4H, and C5H. 
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Compound (2S)-3.12 was obtained as a diastereomeric mixture owing to the newly generated 
chiral center at C4, although these isomers were not separated under our TLC conditions. 1H 
NMR spectra of (2S)-3.12 in CDCl3 (Fig. 2)  showed two sets of C3H protons, for (2S,4R)-
3.12 (δ 2.19 and 1.81 ppm, 0.43 H, respectively) and for (2S,4S)-3.12 (δ 2.00 and 1.95 ppm, 
0.57 H, respectively) (see subsequent discussion for assignments). The geminal couplings 
between the C3H protons of (2S,4R)-6 and also between the C3H protons of  (2S,4S)-3.12 
were clearly observed in the 2D 1H–1H COSY spectrum (Fig. 2,). C4H signals (~δ 2.99 and 
2.96) also appeared as two sets. These diastereomers were assigned with reference to pure 
methyl (2S,4S)-2-Boc-amino-3-(2-oxiranyl)propionate.32 
 This epoxidation of allylglycine derivative 5 (with a –CH2–CH=CH2 side chain) 
slightly favored (2S,4S)-3.12 diastereomer than (2S,4R)-3.12 diastereomer at a ratio of 57:43 
(within 1% error in three independent experiments). In this context, (R)-vinylglycine (with a 
–CH=CH2 side chain) was epoxidized in an 80:20 ratio for (2R,3R)- and (2R,3S)-
diastereomers.26 However no stereoselectivity has been noted for the epoxidation of 
butenylglycine (with a –CH2–CH2–CH=CH2 side chain).29,30 
Intramolecular Cyclization to Generate cis-Hydroxyproline Lactone and trans-
Hydroxyproline Ester. Next, intramolecular attack of the epoxy ring by the amino group of 
the amino acid was performed (Scheme 3). First, the Boc protection of (2S)-3.12 was 
removed by treating with 4 mol/L HCl in dioxane for 2.5 h.31 TLC analysis showed the 
completion of deprotection; the spot of (2S)-3.12 disappeared and a ninhydrin-positive spot 
appeared. The HCl salt of benzyl (2S)-2-amino-3-(2-oxiranyl)propionate ((2S)-3.13·HCl) was 
quantitatively produced as a white solid upon evaporation. After (2S)-3.13·HCl was dissolved 
in DMF (4.6 mmol in 30 mL DMF), two equivalents of Et3N were added to neutralize HCl. 
The free amino group of (2S)-3.13 slowly attacks the epoxy ring intramolecularly. After 24 h, 
TLC analysis (butanol/pyridine/acetic acid/H2O, 4/1/1/2 by volume) of the reaction mixture 
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showed that (2S)-3.13 still remained (Rf = 0.34, purple color with ninhydrin) and also showed 
two ninhydrin-active yellow spots at Rf = 0.52 and 0.79 (a yellow spot on ninhydrin is a 
characteristic of imino acids). After 72 h, TLC results showed that the reactant disappeared, 
and 1H NMR analysis of the evaporated reaction mixture showed the absence of 
characteristic epoxide signals at  2.72 and 2.44 (C5H signals). These facts strongly suggest 
that the nucleophilic ring opening of the epoxide occurred intramolecularly, possibly to 
produce five-membered cyclic imino acids, cis-L- hydroxyproline benzyl ester (cis-3.14 and 
trans-L-hydroxyproline benzyl ester (trans-3.15).  
H2N COOR
O
(2S)-3.13HCl
(2S)-3.12
dioxane
HCl
HCl
Et3N
DMF
H2N COOR
O
N
H
COOR
HO
cis-3.14, trans-3.15
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Boc2O
dioxane/Et3N N COOR
HO
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+
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cis-3.16 trans-3.17
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2
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5 3.18
2
34
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Scheme 4) Formation of N-Boc-L-cis-Hydroxyproline Lactone (3.18) and Benzyl N-Boc-L-
trans-Hydroxyproline (trans-3.17 )(-R = -CH2Ph) 
 
 However, these products (a mixture of L-hydroxyproline benzyl esters cis-3.14 and 
trans-3.15) were not isolated, because their isolation required polar conditions for the silica 
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gel column chromatography. Instead, this reaction mixture was re-dissolved in dioxane and 
reacted with a small excess of Boc2O using Et3N to re-protect the imino acid NH groups to 
give N-Boc-cis-L-hydroxyproline benzyl ester (cis-3.16) and N-Boc-trans-L-hydroxyproline 
benzyl ester (trans-3.17). After 24 h, evaporation and washing with brine afforded the Boc-
protected products as yellow oil. Two spots were observed on TLC, which were ninhydrin 
negative and H3(PMo12O40) positive. 1H NMR analysis was difficult at this stage because the 
spectrum exhibited many overlapping peaks; however, two products were successfully 
isolated by silica gel column chromatography using hexane–50% EtOAc (v/v) as the eluent. 
 
 
 
 
 
 
 
 
 
Figure 3. 1H NMR spectra of (a) 3.18 and (b) trans-3.17 in CDCl3 (high-field region). X 
denotes solvents and known impurities. See figure 4 for CαH, CβH, CγH, and CδH. 
The first eluted product was a white solid and was identified as (1S,4S)-tert-butyl-3- oxo-2-
oxa-5-azabicyclo[2.2.1]heptane-5-carboxylate (L-cis-hydroxyproline lactone, 3.18),9,10,34,35 
not the expected N-Boc-cis-L-hydroxyproline benzyl ester, cis-9. Compound 3.18 was 
obtained as a white solid in 29%–42% yield based on (2S)-3.12. The1H NMR spectrum of 
3.18 showed no signals of a benzyl and -OH group (Fig. 3a,). 
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Figure 4. a) Two conformers of Boc-imino acids. b) NOE signal observed for 3.18. 
 This spectrum is slightly complex because Boc-imino acid exists as a two-rotamers 
major isomer and a minor isomer were observed in the spectrum of 3.18: CH δ 4.92 (0.79H, 
major), 4.65 (0.21H, minor); CH 4.47 (minor), 4.41 (major); CH 2.89 (0.21 H, minor), 2.68 
(0.79 H, major), 2.45 (0.79 H, major), 2.06 (0.21 H, minor). The geminal couplings between 
the CH protons of major isomers and also between those of minor isomers were clearly 
observed in the 2D 1H–1H COSY spectrum. The spin–spin coupling between CH and CH 
was observed only for one set of CH protons, probably because of their dihedral angles. The 
2D NOESY spectrum indicated a NOE signal between CH (δ 2.68 and 2.06) and CH (Fig. 
4b). This NOE signal is the direct evidence for the bicyclic structure of 3.18 because 
monocyclic trans-3.17 showed no NOE signals under the same conditions (see below). The 
most intense peak appeared at m/z = 272 (and 274) of [M+H+Na35Cl]+ (and [M+H+Na37Cl]+) 
in the mass spectrum, where M (213) indicated the intramolecular lactone formation, with no 
signals derived from cis-3.16. 
 The second eluted product from the column was yellowish oil and was identified as 
N-Boc-L-trans-hydroxyproline benzyl ester (trans-3.17). Compound trans-3.17 was obtained 
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as yellowish oil in 18%–38% yield based on (2S)-3.12. The 1H NMR of trans-3.17 (Fig. 3b) 
also indicated a mixture of rotamers but clearly showed the signals of a benzyl group at δ 
7.35 (5H) and ~5.2 (2H). No NOE signals were observed under the same measurement 
conditions used for 3.18; however, an -OH signal was detected at ~3.2 as an exchanging 
proton by phase-sensitive NOESY. The 1H NMR and MS spectra of this sample agreed with 
those of the authentic sample of trans-9 sample, which was separately synthesized from 
commercial N-Boc-L-trans-hydroxyproline and benzyl bromide.35 The mass spectrum of 
trans-3.17 showed peaks at m/z = 322 for [M+H]+ and peaks derived from [M+H]+, where M 
(321) supported the structure of trans-3.17. 
 Comparing the 1H NMR spectrum of trans-3.17 with that of 3.18 reveals significant 
differences in the positions of CH signals (δ 4.92, 4.65 for 3.18 and δ ~4.4 for trans-3.17) 
and CH signals (δ 2.89, 2.68, 2.45, 2.06 for 3.18 and δ 2.31, 2.07 for trans-3.17). 
Interestingly that the high-field-shifted signals in the spectrum of 3.18 compared to trans-
3.17 (CH and CH) showed NOE signals. 
The -OH and -COOCH2Ph groups are closely located in cis-3.16; therefore, lactone 
molecule 3.18 may be intramolecularly formed in the work-up or purification process. 
Fortunately, lactone 3.18 is less polar than cis-3.16 and trans-3.17; therefore, separation 
between 3.18 and trans-3.17 is easy. Thus, practical syntheses of both 3.18 (L-cis-
hydroxyproline derivative) and trans-3.17 (L-trans-hydroxyproline derivative) were 
performed. 
Hydroxyproline Derivatives with (2R)-Stereoconfiguration. To prepare the D-
hydroxyproline derivatives with (2R)-stereoconfigurations, (R)-3.6 obtained by the Subtilisin 
resolution was epoxidized by m-CPBA and saponified to obtain (2R)-2-Boc-amino-3-(2-
oxiranyl)propionic acid ((2R)-3.19) (Scheme 4). This Boc-amino acid with a side-chain 
epoxide group was deprotected with HCl/dioxane, neutralized with Et3N, and then (after 
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Scheme 4. Formation of N-Boc-D-cis-Hydroxyproline Lactone (3.20) and Benzyl N-Boc-
trans-D-Hydroxyoroline (trans-3.21) 
completion of the nucleophilic opening of the epoxide, 72 h) re-protected by Boc2O similar to 
the procedure used to prepare the (2S)-isomeric series (Scheme 3). Silica gel chromatography 
afforded (1R,4R)-tert-butyl-3-oxo-2-oxa-5-azabicyclo[2.2.1]heptane-5-carboxylate (3.20)7 
and N-Boc-D-trans-hydroxyproline benzyl ester (trans-3.21) in 43% and 32% yields, 
respectively. Products 3.20 and trans-3.21 are the mirror images of 3.18 and trans-3.17, 
respectively. The protection of the amino acid -COOH group was not necessary in 
intramolecular cyclization.  
 
3. Experimental section 
 
 General. Reagents and solvents including Subtilisin (Carslberg, from Bacillus 
lichenifirmis) and L-aminoacylase (from Aspergillus genus, 3 x 104 unit/g) were from 
commercial sources. DCM and DMF were used after routine drying. DOWEX 50WX8 (50-
100) was used as an ion exchange resin, after thoroughly washing with aqueous HCl. TLC 
was visualized by UV (F254), I2, H3(PMo12O40), and/or ninhydrin. Daicel CHIRALPAK WH 
column (250 × 4.6 mm) was used for chiral HPLC of the amino acids eluting with 0.25 
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mmol/L CuSO4 (1.0 mL/min). 50 oC, and 220 nm detection. 1H NMR spectra (1D, 2D-COSY, 
2D-NOESY) were measured in CDCl3 or CD3OD at 500 or 600 MHz. Normal- and high 
resolution-FAB mass and ESI TOF mass spectra were measured routinely. Optical rotations 
were measured in a 100 mm cell at 26 oC. 
 Kinetic Resolutions of 2-Amino-4-pentenoic Acid Derivative by Subtilisin. 
Racemic Ethyl 2-Boc-amino-4-pentenoate (3.6).21 3.5 (25.4 mL, 100 mmol) and NaOEt 
(100 mmol) in 100 mL EtOH was refluxed for 30 min. Allyl bromide (11.2 mL, 130 mmol) 
was added to the above cooled mixture and further refluxed for 5 h. AcOH (5.7 mL) was 
added after cooling, then the mixture was evaporated, dissolved in EtOAc, washed (brine), 
and again evaporated to obtain diethyl 2-allyl-(2-Boc-amino)malonate (28.7 g), which was 
sufficiently pure for further synthesis. 
 To the EtOH (60 mL) solution of diethyl 2-allyl-(2-Boc-amino)malonate (16.3 g, 51.7 
mmol), 60 mL of aqueous NaOH (1.0 mol/L) was added at 0 oC. After 3 h, the mixture was 
concentrated, acidified (pH 3, citric acid), and extracted with EtOAc. After evaporation, 
crude ethyl 2-Boc-amino-2-ethoxycarbonyl-4-pentenoate was obtained (15.2 g). This ester 
was not purified but dissolved in 100 mL toluene and refluxed for 6 h. Racemic 3.6 was 
obtained after evaporation as a viscous liquid (12.5 g, 51.4 mmol, 91% based on diethyl (2-
Boc-amino)malonate). 1H NMR (CDCl3): δ 5.70 (m, 1H, C4H), 5.13 (m, 2H, C5H), 5.06 (d, J 
= 7 Hz, 1H, NH), 4.36 (q, J = 7 Hz, 1H, C1H), 4.20 (m, 2H, OCH2), 2.55 and 2.50 (m, total 
2H, C2H), 1.44 (s, 9H, Boc), 1.28 (t, J = 7 Hz, 3H, OCH2CH3), which was similar to the 
reported one.23 
 (S)-2-Boc-amino-4-pentenoic acid ((S)-3.7). The solution of racemic 1 (17.4 g, 71.5 
mmol) in 72 mL DMF was diluted with 200 mL H2O, then 70 mg (~840 units) of Subtilisin 
was added. The mixture was stirred at 40 oC for 3 h, while maintaining its pH at 8.0 (aqueous 
NH3). The mixture was extracted by diethyl ether, then the remaining aqueous solution was 
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acidified (pH 3, citric acid). (S)-2 was extracted with EtOAc, washed (brine), and evaporated 
to yield 7.53 g (35.0 mmol, 49% based on racemic 1) as an oil. HPLC (after removal of Boc 
with 4 mol/L HCl in dioxane): retention time 23.18 min. [α]D26 = +9.65o (c = 1.3, MeOH). 1H 
NMR was similar to the literature.22 
  Ethyl (R)-2-Boc-amino-4-pentenoate ((R)-3.6). The diethyl ether extract of the 
Subtilisin reaction mixture was evaporated to afford (R)-1 (8.54 g, 35.1 mmol, 49% based on 
racemic 1). HPLC (after removal of -OEt with 1 mol/L aqueous NaOH, 2 h, then Boc 
removal): retention time 19.38 min. 
 Kinetic Resolutions of 2-Amino-4-pentenoic Acid Derivative by Acylase. Racemic 
2-Acetamido-4-pentenoic Acid (3.9). 3.8 (10.0 g, 46.0 mmol) and NaOEt (50.7 mmol) was 
refluxed in 40 mL EtOH for 5 h, then allyl bromide (5.0 mL, 59 mmol) was added to the 
cooled reaction mixture and further refluxed for 15 h. After cooling, neutralized (2 mL 
AcOH) mixture was evaporated, taken up in EtOAc, washed (brine), and again evaporated to 
obtain an oily diethyl 2-acetylamido-2-allylmalonate quantitatively (11.9 g). 
 This crude malonate (11.9 g, supposed to be 46.0 mmol) dissolved in 45 mL EtOH 
was mixed with 56 mL aqueous NaOH (1.0 mol/L) at 0 C. The reaction was complete after 3 
h (TLC), then EtOH was evaporated, the remaining aqueous solution was washed (diethyl 
ether), acidified (pH 2, aqueous HCl), and extracted with EtOAc. Evaporation of the organic 
phase afforded white solid of ethyl 2-acetamido-2-(ethoxycarbonyl)-4-pentenoate (10.8 g), 
which was sufficiently pure for further synthesis.  
 A part of this ethyl 2-acetamido-2-(ethoxycarbonyl)-4-pentenote (9.30 g, 39.6 mmol) 
was refluxed in 90 mL toluene for 24 h, which afforded crude ethyl 2-(acetamido)-4-
pentenoate (5.92 g) after evaporation. This crude ethyl ester was hydrolyzed with excess 
NaOH (two batches) in EtOH–H2O (1.3:1, v/v) at 0 C for 3 h. After evaporation of EtOH, 
the remaining aqueous solution was washed (diethyl ether), acidified (aqueous HCl), and 
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extracted with EtOAc. Evaporation of the organic phase afforded racemic 3.9 as a creamy oil 
(total 2.29 g, 14.6 mmol, 37% from diethyl acetamidomalonate). 1H NMR (CDCl3, Figure 
A1): δ 6.00 (d, J = 7 Hz, 1H, NH), 5.74 (m, 1H, C4H), 5.19 (m, 2H, C5H), 4.65 (m, 1H, C2H), 
2.64 and 2.59 (m, 2H, C3H), 2.06 (s, 3H, Ac). 
 (S)-2-Amino-4-pentenoic Acid ((S)-3.10). Racemic 3.9 (1.60 g, 10.2 mmol) and 
CoCl2·6H2O (11 mg, 50 μmol) was dissolved in 16 mL H2O at 37 C, while maintaining its 
pH at 7.0 with aqueous LiOH (ca. 14 mL). L-Aminoacylase (0.46 g, 13 800 units) in 4.0 mL 
H2O was added. After 24 h, while adjusting the pH at 7.0 with small amount of aqueous NH3, 
the reaction mixture was concentrated, acidified to pH 1.5 (aqueous HCl), and the unreacted 
(R)-3 was extracted with EtOAc. 
 The acidic aqueous phase was applied to a column of ion exchange resin (DOWEX 
50WX8, 150 × 20 mm). After sample charging and washing with 1.0 mol/L aqueous HCl, 
(S)-4 eluted with 1.0 mol/L aqueous NH3. Evaporation of the eluent afforded (S)-3.10 as 
white solids (330 mg, 2.87 mmol, 28 % based on racemic 3). HPLC: retention time 23.60 min. 
1H NMR (CD3OD): δ 5.81 (m, 1H, C4H), 5.22 (m, 2H, C5H), 3.58 (m, 1H, C2H), 2.66 and 
2.57 (m, 2H, C3H), which was identical to the commercial sample. 
 (R)-2-Acetamido-4-pentenoic Acid ((R)-3.9). The EtOAc extract of the acidified 
acylase reaction mixture was evaporated to give (R)-3 as a brown oil (2.53 g). A part (1.75 g) 
of this sample was chromatographed over silica gel (CHCl3:MeOH:AcOH = 90/10/2, by 
volume) to afford pure (R)-3 as a semi-solid (249 mg, 1.58 mmol, 22% based on racemic 3). 
HPLC (after removal of Ac by 1 mol/L aqueous HCl, reflux):27 retention time 19.53 min. 
 Epoxidation in the Side Chain of (S)-3.11. Benzyl (S)-2-Boc-amino-4-pentenoate 
((S)-3.11). To the solution of (S)-3.7 (6.93 g, 32.2 mmol) in 100 mL DMF, benzyl bromide 
(5.13 g, 45.0 mmol) and Et3N (2.43 g, 36 mmol) was added at 0 oC. After 5 h, the mixture 
was evaporated, taken up in EtOAc, washed (aqueous citric acid/aqueous NaHCO3), and 
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again evaporated. The residue was chromatographed over silica gel (CHCl3–1% MeOH, v/v) 
to obtain pure (S)-3.11 (6.32 g, 20.7 mmol, 64%) as an oil. 1H NMR (CDCl3):  7.36 (m, 5H, 
Ph), 5.65 (m, 1H, C4H), 5.17 (m, 2H, CH2Ph), 5.1 (m, 3H, overlap of NH and C5H), 4.43 (q, J 
= 7 Hz, 1H, C2H), 2.52 (m, 2H, C3H), 1.43 (s, 9H, Boc), which was similar to the literature.36 
 Benzyl (2S)-2-Boc-amino-3-(2-oxiranyl)propionate ((2S)-3.12). To the ice-cooled 
solution of (S)-3.11 (8.00 g, 26.2 mmol) in 100 mL DCM, m-CPBA (9.59 g, 40.0 mmol) in 50 
mL DCM was added in 5 portions and warmed to room temperature. After 24 h, the solution 
was concentrated to ca. 1/4 volume and was mixed with Na2SO3 solution (3.0 g in 25 mL 
H2O). The biphasic mixture was stirred vigorously for 2 h, then the organic phase was 
washed (aqueous NaHCO3) and evaporated to obtain the crude (2S)-3.12 (9.26 g) as a white 
syrup, which was purified by silica gel column chromatography (hexane–15% EtOAc, v/v) to 
obtain pure (2S)-3.12 (5.79 g, 18.0 mmol, 69%) as a colorless oil. 1H NMR (CDCl3, Figure 2, 
A2, A3,A4):  7.36 (m, 5H, Ph), 5.31 (d, 1H, J = 8 Hz, NH), 5.19 (m, 2H, CH2Ph), 4.52 (m, 
1H, C2H), 2.99 (m) and 2.96 (m) (C4H of (2S,4R)-6 and C4H of (2S,4S)-3.12, respectively, 
total 1H), 2.72 (t, 1H, J = 5 Hz, C5H), 2.44 (m, 1H, C5H), 2.19 (m, 0.43H, C3H of (2S,4R)-6), 
2.00 (m, 0.57H, C3H of (2S,4S)-6), 1.95 (m, 0.57H, C3H of (2S,4S)-3.12), 1.81 (m, 0.43H, 
C3H of (2S,4R)-6), 1.45 (s, 9H, Boc); MS (FAB): m/z 344 ([M+Na]+, 7), 322 ([M+H]+, 14), 
266 ([M+H–C4H8]+, 100), 222 ([M+H–C4H8–CO2]+, 38); HR-MS (FAB): calc for C17H24NO5 
([M+H]+), 322.1655, found 322.1639. 
 Intramolecular Epoxide Opening to Generate cis-Hydroxyproline Lactone and 
trans-Hydroxyproline Ester. tert-Butyl (1S,4S)-3-oxo-2-oxa-5-azabicyclo[2.2.1]heptane-
5-carboxylate (3.18) and N-Boc-(2S,4R)-4-hydroxyproline benzyl ester (trans-3.17). (2S)-
3.12 (1.49 g, 4.64 mmol) in 3.0 mL of dioxane was added to the ice-cooled solution of HCl in 
dioxane (4 mol/L, 40.0 mL) within 5 min and warmed to room temperature. After 2.5 h, the 
solution with white precipitate was evaporated and kept in vacuo overnight. HCl salt of 
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benzyl 2-amino-3-(2-oxiranyl)propionate ((2S)-3.13·HCl) was obtained quantitatively (1.20 
g) as a white oily solid.  
 (2S)-3.13·HCl thus obtained was dissolved in 30 mL of DMF, then Et3N (1.3 mL, 9.3 
mmol) was added and the resultant yellowish mixture was stirred for 72 h. After evaporation, 
a white solid was yielded (1.51 g). A mixture of (2S,4S)-4-hydroxyproline benzyl ester 
((2S,4S)-3.14) and (2S,4R)-4-hydroxyproline benzyl ester ((2S,4R)-3.15) were obtained 
quantitatively, which were analyzed by TLC and 1H NMR, but these benzyl esters were not 
isolated. Instead, some of this crude benzyl esters (1.40 g, 4.30 mmol) was mixed with 30 mL 
of dioxane, then Et3N (0.59 mL, 4.23 mmol) and Boc2O (1.13 g, 5.18 mmol) in 3.0 mL 
dioxane was added. After 18 h, the mixture was concentrated, dissolved in EtOAc, washed 
(brine), and evaporated to afford yellow oil (1.12 g). 0.49 g (calculated to be 1.88 mmol) of 
this crude product was purified by silica gel column chromatography (hexane–50% EtOAc, 
v/v) to obtain pure 3.18 (yellowish solid after crystallization from EtOAc, 115 mg, 539 μmol, 
29%) and trans-3.17 (brownish oil, 106 mg, 330 μmol, 18%). 
 tert-Butyl (1S,4S)-3-oxo-2-oxa-5-azabicyclo[2.2.1]heptane-5-carboxylate (3.18). 
1H NMR (CDCl3, Figures 3, A4, A5, A6):  4.92 (br s, 0.79H, CγH of major isomer), 4.65 
(sixtet, J = 5 Hz, 0.21H, CγH of minor isomer), 4.47 and 4.41 (both m, total 1H, CαH of 
minor and major isomers, respectively), 3.66~3.79 (m, 2H, CδH), 2.89 (m, 0.21 H, CβH of 
minor isomer), 2.68 (t, J = 20 Hz, 0.79 H, CβH of major isomer), 2.45 (dt, J = 10 and 13 Hz 
0.79 H, CβH of major isomer), 2.06 (q, J = 11 Hz, 0.21 H, CβH of minor isomer), 1.46 (s, 9H, 
Boc), which were similar to the literature.ref38 MS (ESI, Figure A8): m/z 272 
([M+H+Na35Cl]+), 274 ([M+H+Na37Cl]+), 216 ([272–C4H8]+). 
 N-Boc-(2S,4R)-4-hydroxyproline benzyl ester (trans-3.17). 1H NMR (CDCl3, 
Figure 3):  7.35 (m. 5H, Ph), 5.07~5.27 (m, 2H, CH2Ph), 4.44~4.48 (m, 2H, CαH, CγH), 3.65 
(minor isomer) and 3.63 (major isomer) (both d, J = 4 Hz, total 1H, CδH), 3.56 (major 
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isomer) and 3.45 (minor isomer) (both d, J = 12 Hz, total 1H, Cδ'H), 3.27-3.16 (m, 1H, OH), 
2.31 (m, 1H, CβH), 2.07 (m, 1H, CβH), 1.46 (s, 3.2H, minor isomer, Boc), 1.35 (s, 5.8H, 
major isomer, Boc). MS (FAB): m/z 322 ([M+H]+, 26), 266 ([322–C4H8]+, 76), 222 ([322–
C4H8–CO2]+, 100). 
 cis-Hydroxyproline Lactone and trans-Hydroxyproline of (2R)-isomers. (2R)-2-
Boc-amino-3-(2-oxiranyl)propionic acid ((2R)-3.19). The reaction of (R)-3.6 (7.30 g, 30.0 
mmol) with m-CPBA (1.5 equivalent) in DCM, in a similar manner to the synthesis of (2S)-
3.12, yielded ethyl (2R)-2-Boc-amino-3-(2-oxiranyl)propionate (5.98 g, 23.1 mol, 77%). 
Without purification, 3.63 g of this ethyl ester (14.9 mmol) in 50 mL EtOH was mixed with 
17 mL aqueous NaOH (1.0 mol/L) at 0 oC. After 2 h, AcOH (1.2 mL) was added and EtOH 
was evaporated. The remaining aqueous solution was washed (diethyl ether/aqueous 
NaHCO3), acidified, and extracted with EtOAc. Evaporation of the organic phase afforded 
(2R)-3.19 (2.31 g, 10.0 mmol, 55% from (R)-3.6 in two steps). 1H NMR (CD3OD): δ 4.63 (d, 
1H, C2H), 4.49 (m, 1H, C4H), 3.77 (m, 1H, C5H), 3.61 (m, 1H, C5H) , 2.46, 2.34, 2.02 (m, 
total 2H, C3H), 1.44 (s, 9H, Boc). MS (FAB): m/z = 254 ([M+Na]+, 29), 232 ([M+H]+, 29), 
176 (([232–C4H8]+, 100). 
 tert-Butyl (1R,4R)-3-oxo-2-oxa-5-azabicyclo[2.2.1]heptane-5-carboxylate (3.20) 
and N-Boc-(2R,4S)-4-hydroxyproline ethyl ester (trans-3.21). (2R)-3.19 (2.71 g, 11.7 
mmol) was added to the HCl solution in dioxane (4 mol/L, 25 mL, 0 oC) and warmed to room 
temperature. After 1 h, the mixture was evaporated to obtain (2R)-2-amino-3-(2-
oxiranyl)propionic acid quantitatively. This (2R)-2-amino-3-(2-oxiranyl)propionic acid was 
dissolved in 40 mL DMF, then Et3N (2.00 mL, 14.4 mmol) was added and the resultant 
mixture was stirred for 72 h. Boc2O (2.55 g, 11.7 mmol) and Et3N (1.63 mL, 11.7 mmol) 
were further added. After 8 h, the mixture was concentrated, dissolved in EtOAc, washed 
(aqueous citric acid), and evaporated to obtain yellow oil (1.45 g). This crude product was 
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purified by silica gel column chromatography (hexane–50% EtOAc, v/v) to obtain 3.207 
(1.07 g, 5.03 mmol, 43%) and trans-3.21 (866 mg, 3.74 mmol, 32%). 
  
4. Conclusion 
In summary, (2S,4R)-, (2S,4S)-, (2R,4S)-, and (2R,4R)-hydroxyproline derivatives were 
synthesized. The configuration of the chiral center at C2 position was determined by the 
enzymatic resolution of a chiral amino acid ester (Subtilisin) or an acetyl amino acid 
(acylase). Racemic 2-amino-4-pentenoic acid in its protected form was resolved to L- and D-
amino acids in enantiomerically pure forms. After the epoxidation of the side chain by 
treatment with m-CPBA, the amino acids with side-chain epoxide groups were subjected to 
the nucleophilic attack of the amino acid H2N- group on the epoxide. Intramolecular 
cyclization generated 4-hydroxyproline with five-membered rings.  
 The chiral center at the C4 position was generated with low stereoselectivity; however, 
4-hydroxyproline derivatives with cis orientations, i.e., (2S,4S)- and (2R,4R)-hydroxyproline 
derivatives, formed bicyclic lactone molecules. Intramolecular ester exchange reactions, i.e., 
attack of the benzyl ester moieties by the 4-OH group, occurred. The lactone molecules were 
more hydrophobic than hydroxyprolines; therefore, the silica gel column chromatographic 
separation of (2S,4R)-isomer (L-hydroxyproline) and (2S,4S)-isomer (L-cis-hydroxyproline 
lactone) was straightforward. Thus, stereoisomers of hydroxyproline derivatives were 
prepared successfully. 
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Chapter 4 
 
Chemoenzymatic synthesis of 5-hydroxy 
pipecolic acid via Jacobsen's hydrolytic kinetic 
resolution of epoxy amino acids1 
 
1. Introduction 
  
 In chapter 1, the synthetic methods for the 5-hydroxypipecolic acid were discussed. 
However most of this methods suffer from low yield, costly starting material, and give rise to 
products that are water soluble and need to be separated by ion exchange chromatography. 
For instance L-allylsine ethylene acetal (4.1, Fig 1), used to synthesize 5-hydroxypipecolic 
acid is a very expensive starting material.1a Moreover it gives rise to a single product of the 
four possible stereoisomers of 5-hydroxypipecolic acid. Although (Bailey & Bryans)14 
improved the number of stereoisomers formed in their protocol to two, their method suffers 
from the use of hazards chemicals, like diazomethane and hydrofluoric acid (Scheme 2). 
Finally the synthesis of 5-hydroxypiecolic acid starting from L-pipecolic acid (Scheme 3) 15-18 
even though is a green method, without the use of hazardous oxidizing agent, again had the 
drawback of expensive starting materials. Additionally this protocol gives rise to product 
which is water soluble and need separation by ion exchange chromatography. The synthesis 
                                                             
1 Reproduced by permission of The Royal Society of Chemistry© from my publication (Reference  no 24) 
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of 5-hydroxypiecolic acid starting from L-pipecolic acid (4.2, Fig.1) 2-5 is a green  and 
attractive method, without the use of hazardous oxidising agent. But has the drawback of 
expensive starting materials and non-availability of the enzyme commercially. Additionally 
this protocol gives rise to product which are water soluble and need separation by ion 
exchange chromatography. 
 
N CO2H
H
4.2
CO2HH2N
O
O
4.1  
 
Figure 1) 4.1-640 US$/g; 4.2-1105 US$/g; Sigma-Aldrich® 
 In this context glycine amino acid residues functionalized with epoxide side chains 
are synthetically valuable precursors for generation of cyclic amino acids. In the previous 
chapter  we described the synthesis of 4-hydroxyproline (A, Sc.1) isomers from epoxide 
derived from 2-amino-4-pentenoic acid (allyl glycine) by selective intramolecular reaction of 
amine on C5 carbon.6 Similarly the synthesis of 5-hydroxypipecolic acid can be achieved by 
selective attack of amino group on C6 carbon of 2-amino-5-hexenoic acid epoxide (B, Sc. 1).  
 
H2N
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O
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N
H
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CO2R
A B
 
Scheme 1) (A) Synthesis of 4-hydroxy proline. (B) Synthesis of 5-hydroxypipecolic acid. 
 
Several reports exists on the synthesis of 5-hydroxypipecolic acid derivatives via 
intramolecular reactions of epoxy amino acid.7-9  However these synthetic procedures yield an  
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unresolved diastereomeric mixture of desired cis- and trans-5-hydroxypipecolic acids, along 
with the undesirable 5-hydroxymethylprolines.7,9 
 
HN
O
N
H
HO
CO2H
CO2Et
CO2Et
O
H
a
b
a
b
N
H
HO
CO2H
N
H
HO CO2H N
H
HO CO2H
4.4 4.5
4.6 4.7
1)1N NaOH
   37 C, 3 days
   
2)12 M HCl
    reflux, 5 h
    -CO2
4.3
 
 
Scheme 2) Synthesis of 5-hydroxypipecolic acid from epoxide cyclization. 
 
 Witkop and Folts7 attempted the synthesis of 5-hydroxypipecolic acid from epoxide 
derived form 2-mino-5-hexenoic acid (Scheme 2). 4.3 was treated with excess of 1N NaOH 
at 37 C for 3 days which gave rise to cyclic amino acids, as shown by ninhydrin analysis. 
The mixture was then decarboxylated by refluxing in 12 M HCl. Subsequently the reaction 
mixture was purified by (Dowex-50®) ion exchange resin. Pathway a was apparently favored 
over pathway b. The yields were 10% of (4.6 and 4.7) and 35 % of (4.4 and 4.5). D. S. Kemp 
and T. P. Curran9 attempted the synthesis with a similar epoxide and results were same to 
Witkop et al. Scheme 3. 
Hence a straightforward method generating 5-hydroxypipecolic acid derivatives bypassing 
the laborious need to isolate the cis- and trans- diastereomers in the final stages combined 
with elimination of  the formation of regioisomeric proline is desired. In this project we 
wanted to devise a synthetic scheme circumventing the drawbacks imposed by the established 
synthetic procedures involving generation of 5-hydroxypipecolic acid by intramolecular 
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Scheme 3) Synthesis of 5-hydroxypipecolic acid from epoxide cyclization. 
 
reaction of epoxy amino acid. Here the S and R isomers were efficiently separated by 
enzymatic kinetic resolution. Whereas the epoxide precursors that give rise to cis- and trans- 
isomers of 5-hydroxypipecolic acid were separated via Jacobsen's Co catalysed HKR. A 
general scheme is shown in the (Scheme 4) 
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O CO2EtN
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CO2EtN
(RR)-Co-salen OH
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N CO2Et
HO
Boc
N CO2Et
HO
Boc
Boc
H
H
Boc
Boc
H
 
Scheme 4) A general scheme of this synthesis. 
 
 
2. Results and Discussion. 
 
L-acylase catalysed enzymatic resolution of 2-amino-5-hexenoic acid derivatives. 
Enatiomerically pure 2-amino-5-hexenoic acid derivatives were synthesized by enzymatic 
resolution of acetyl amino acid with L-acylase (Scheme 5). 
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CO2Et
CO2Et
AcHN
CO2EtAcHN
EtO2C
CO2HAcHN CO2HH2NCO2HAcHN
4.11 4.12 (RS)-4.13 (R)-4.13 (S)-4.14
i ii iii
CO2HH2N
(S)-4.14
iv
CO2HAcHN
(S)-4.13  
Scheme 5) L-acylase based resolution of 2-amino-5-hexenoic acid. i) a. NaOEt, EtOH, reflux; 
b. 4-bromo-1-butene, reflux, 24 h. ii) NaOH, EtOH:H2O (1:1), reflux, 24 h, (47%). iii) L-
acylase, pH = 7.5, 38 C, 24 h. iv) Ac2O, K2CO3, MeOH, 75%. 
 
 Diethyl acetamidomalonate (4.11) (Scheme 7), was reacted with excess of 4-bromo-1-
butene in the presence of sodium ethoxide in absolute ethanol to obtain the alkylated diester. 
The diester was half saponified and decarboxylated simultaneously, by treating with soild 
NaOH in EtOH:H2O mixture (1:1, v/v) and refluxing for 24 h to give the desired racemic 
acetyl amino acid (RS)-4.13, (47 % overall yield based on 5) suitable for the L-acylase 
catalyzed enzymatic resolution. 
 An aqueous solution of (RS)-4.13, maintained at 38 C, with pH 7.5 adjusted with 
LiOH (aq) was treated with L-aminoacylase from Aspergillus genus.10 After 24 h, the 
solution was concentrated and acidified with 1M HCl to pH 3 and extracted with 
EtOAc to remove the unreacted (R)-4.13 (41%). The remaining acidic solution was 
passed through ion exchange resin (DOWEX 50WX8) to separate (S)-4.14 (32%) 
which was selectively eluted with NH4OH (1M). Due to the high water solubility of 
the acetyl amino acid the yields were less, but pure D- and L-2-amino-5-hexenoic acid 
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were obtained with good chemical and enatiomeric purity ascertained by 1H NMR and 
chiral HPLC. 
-chymotrypsin catalysed enzymatic resolution of 2-amino-5-hexenoic acid 
derivatives 
 
CO2Et
CO2Et
BocHN
CO2EtBocHN
EtO2C
CO2HBocHN CO2EtBocHN
4.15 (RS)-4.16
(S)-4.17 (R)-4.16
i ii iii
CO2Et
CO2HBocHN CO2EtBocHN
(R)-4.16
CO2EtBocHN
(R)-4.17
CO2HBocHN
iv
v
 
 
Scheme 6) -chymotrypsin based resolution of 2-amino-5-hexenoic acid. i) a. NaOEt, EtOH, 
reflux; b. 4-bromo-1-butene, reflux, 24 h. ii) LiOH.H2O, EtOH:H2O (18:8), 0 C, 12 h. 
iii)Toluene, reflux, 18h (59%). iv) -chymotrypsin, buffer, pH-8, Ac2O, K2CO3, MeOH, 75%. 
 
Subsequently diethyl (2-Boc-amino)malonate (4.15), was treated with excess 4-
bromo-1-butene in presence of sodium ethoxide to obtain alkylated diester. The later 
was selectively saponified with solid LiOH to obtain the half acid half ester, which 
was successfully decarboxylated in refluxing toluene to obtain (RS)-4.16 (59 % overall 
yield with respect to 4.15), Scheme 6. 
 Enzymatic resolution was carried by suspending the racemic (RS)-4.16 in phosphate 
buffer (pH 8, 0.1 mmol) at 38 C and treating with -chmotrypsin. To avoid slight 
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deviance of pH caused by formation of (S)-4.17, minimal amount of NH4OH (1M) 
was added and maintained at pH 8. After 24 h, the mixture was cooled to room 
temperature and alkalinity was enhanced by addition of (4% NaHCO3) followed by 
extraction with EtOAc to recover unreacted (R)-4.16 (51 %). The remaining alkaline 
aqueous solution was subsequently acidified with solid citric acid to pH 3, extracted 
with EtOAc to obtain (S)-4.17 (46%). 
 
CO2RHN
Boc
CO2EtHN
Boc
O
CO2EtHN
Boc
O
R = H; (S)-4.17
R = Et; (S)-4.16
i
inseparable diastereomers
           (S)-4.18  
Scheme 7) i) m-CPBA, DCM, 24 h, 90 % 
 
m-CPBA oxidation.(Scheme 7) 
Kinetically resolved Boc-amino acid (S)-4.17 was esterified with ethyl bromide in the 
presence of Et3N to obtain (S)-4.16 in 84% yield. This fully protected Boc-amino acid 
ester with unsaturated side chain was epoxidized with excess 3-chloroperbenzoic acid 
(m-CPBA) by treating the solution of (S)-4.16 in DCM with excess m-CPBA at 0 C, 
followed by 24 h stirring at room temperature. Subsequently excess m-CPBA was 
cautiously reduced with 10% Na2SO3 at 0 C. The DCM layer was separated and 
washed (4% NaHCO3 and brine), concentrated and chromatographed (SiO2) to obtain 
(S)-4.18 (90%, yield). 
 The epoxide resulted was a diastereomeric mixture due to newly generated chiral 
centre at C5 carbon. However the diastereomers moved as a single spot with same Rf 
value on TLC, and did not lead to their separation.1H NMR analysis in (CDCl3) did 
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not show any set of distinguishable peaks for the individual diastereomers. In this 
context m-CPBA oxidation of similar epoxides is believed to produce 1:1 mixture of 
both diastereomers. All the efforts directed towards the separation of the diastereomers 
at this stage were futile. Hence the epoxide diastereomers were used as a such without 
further modification.8,11 
(RR)-Co-Salen, AcOH
CO2EtHN
Boc
O
CO2EtHN
Boc
O
(2S,5R)-4.19
47%
(2S,5S)-4.20
46%
CO2EtHN
Boc
OH
HO
(S)-4.18
H2O (0.55 eq),
 THF, 48 h
 
 
Scheme 8) Jacobsen hydrolytic kinetic resolution 
 
Hydrolytic kinetic resolution (HKR) of  epoxy amino acids.12,13 (Scheme 8) 
To aid the separation of the diastereomeric epoxide, (S)-4.18 was treated with (0.55 
eq) of H2O in the presence of (0.5 mol%) of (RR)-Co-Salen and AcOH, at room 
temperature in THF. This produced the chiral diol (2S,5S)-4.20 and chiral epoxide 
(2S,5R)-4.19 which had a considerable Rf difference. In fact the chiral epoxide 
(2S,5R)-4.19 and chiral diol (2S,5S)-4.20, were easily separated by silica gel column 
chromatography in good yield, 47% and 46%, respectively. 
tert-butoxycarbonyl (Boc) removal and intramolecular cyclization.(Scheme 9)  
Next, the chiral epoxide (2S,5R)-4.19 was treated with LiBr in the presence of AcOH 
in THF, which attacked the C6 carbon selectively giving rise to  bromo hydrin (2S,5R)-
4.21.14 This bromo amino acid was isolated in good yield (92%) after (SiO2) 
purification, which was suitable for synthesis of 5-hydroxypipecolic acid. To aid the 
intramolecular cyclization Boc group of (2S,5R)-4.21 was removed by treating it with 
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Scheme 9) Boc removal and intramolecular cyclization 
 
TFA. After 1h the TFA was removed to obtain, 4.22.TFA in quantitative yield which 
was not purified owing to its hydrophilic character, instead it was used for next step 
directly.  
 4.22.TFA, was dissolved in THF at room temperature and treated with DIEA (2 eq) 
and stirred. DIEA treatment leads to the neutralization of  TFA and simultaneously 
gives rise to highly nucleophilic and free amine. This amine will then attack 
intramolecularly the C6 carbon, there by producing the 5-hydroxypipecolic acid. Due 
to the formation of HBr after intramolecular cyclization, another equivalent of DIEA 
was required to neutralize this and complete the cyclization. TLC analysis at the end 
of 4 h, (butanol/pyridine/acetic acid/H2O, 4:1:1:2, v/v/v/v) by staining with ninhydrin 
showed the absence of the reactant and appearance of a yellow spot, which is 
characteristic of the cyclic amino acids. This confirmed that the nitrogen 
intramolecularly attacked the side chain to produce the piperidne ring, i.e., (2S,5R)-
4.23. To aid the purification process the nitrogen of the imino acid was again 
reprotected with Boc group by treatment with Boc2O in presence of DIEA to generate 
the Boc-5-hydroxypipecolic acid derivatives. 5-hydroxypipecolic acid, (2S,5R)-4.24 
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was separated as an oil (80%) by silica gel column chromatography (50% EtOAc in 
hexane). 
 Subsequently the oil (2S,5R)-4.24 was converted to 1.HCl. The spectral data, 
melting point and specific rotation of 1.HCl, were in good agreement with the 
reported values.16 
CO2EtBocHN
OTs
HO
(2S,5S)-4.25
N CO2Et
HO
(2S,5R)-4.27
CO2EtBocHN
OH
HO
TsCl
Bu2SnO
DMAP, DCM
NaI
acetone
reflux
CO2EtBocHN
I
HO
i-iii
(2S,5S)-4.20 (2S,5S)-4.26
N CO2H
HO
HBoc
2
Ref 15
 
 
Scheme 10) Formation of (2S,5S)-hydroxypipecolic acid by intramolecular cyclization i.TFA; 
ii. DIEA, THF; iii. Boc2O, DIEA,THF. 
 
Regioselective halogenation, N-Boc removal and intramolecular cyclization. 
In order to transform the chiral diol (2S,5S)-4.20 into 5-hydroxypipecolic acid, it was 
necessary to transform (2S,5S)-4.20 into amino acid with a good leaving group at C6 
carbon. This was achieved by selective tosylation of diol by treating with TsCl in the 
presence of catalytic Bu2SnO (30 mol%), DMAP (cat.) and triethylamine at -10 C, 
yielding the mono tosylated product in almost quantitative yield.17-19 The temperature 
was maintained between -10 C to 0 C in order to retain the acid labile Boc group. 
The tosyl group in (2S,5S)-4.25 was replaced with iodo group by refluxing it in the 
presence of NaI (6 eq) in acetone. After 8 h, acetone was replaced with EtOAc washed 
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with (sat.Na2S2O3), brine, and chromatographed on (SiO2) resulting (2S,5S)-4.26 
(95%) used for synthesis of 5-hydroxypipecolic acid (Scheme 5).  
 To aid the intramolecular cyclization Boc group of (2S,5S)-4.26 was removed by 
treating with TFA at room temperature. After 1h the solution was concentrated to 
obtain Boc- deprotected amino acid salt of TFA in quantitative yield, which was used 
for subsequent step directly.  
 After dissolving in THF at room temperature and treating it with DIEA (2 eq) free 
amine was generated. The free amine attacked the C6 carbon intramolecularly thereby 
generating 5-hydroxypipecolic acid. After 3 h, to aid the purification process the 
nitrogen of the imino acid was again reprotected with Boc group by treating with 
Boc2O in presence of DIEA to generate the Boc-5-hydroxypipecolic acid derivatives. 
The fully protected 5-hydroxypipecolic acid (2S,5S)-4.27 was easily separated as an 
oil by silica gel column chromatography (50% EtOAc in hexane) in 76 % yield. 
Subsequently the oil (2S,5S)-4.27 was converted to 2.HCl. The spectral data, melting 
point and specific rotation of 2.HCl, were in good agreement with the reported 
values.20,21 
The synthesis of (2R)-isomers were achieved starting from (R)-4.16 as shown in (Sc. 11). By 
following the same procedure described for (S)-isomers. 
 
3. Experimental section 
 
General: Reagents, dry solvents, and enzymes were from commercial sources. 
DOWEX 50WX8 (50–100) was used as an ion exchange resin, after washing with 1M 
HCl. (R,R)-(−)-N,N′-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminocobalt 
(II) was purchased from Sigma-Aldrich®. TLC was visualized by one of the 
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following, UV (F254), I2, H3(PMo12O4) or ninhydrin. Chiral HPLC analysis were 
performed on Column I: CHIRALPAK IA column (4.6 × 250 mm, Diacel Chemical 
Industries, Ltd.), n-hexane:2-propanol:TFA (97:3:0.1, v/v/v) with a flow rate of  
1mL/min, detection at 220 nm; Column II: CHIRALCEL OD column (4.6 × 250 mm, 
Diacel Chemical Industries, Ltd.), n-hexane:2-propanol:TFA (90:10:0.1) with a flow 
rate of 1mL/min, detection at 220 nm. 1H were measured in CDCl3, CD3OD or D2O at 
500 or 400 MHz  and 13C NMR were measured in CDCl3, CD3OD or D2O at 125 
MHz. Normal- and high resolution-FAB mass were measured routinely. Optical 
rotations were measured using Jasco Polarimeter (P-1010). Melting point (m.p.) were 
recorded by As One melting point instrument (Model Number ATM-01). 
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Scheme 11) Synthesis of (2R) isomers. 
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Kinetic resolutions by L-acylase from Aspergillus genus.  
 
(RS)-2-(acetamido)-5-hexenoic acid (RS)-6. Sodium metal (5.10 g, 222.0 mmol) was 
added to a flask containing 195 mL of absolute ethanol maintained at  0 C. After 
complete dissolution of sodium, 5 (43.5 g, 200 mmol) was added in one portion and the 
resulting solution was refluxed. After 3h to this refluxing solution 4-bromo-1-butene (25.0 g, 
185 mmol) was added and continued to reflux. After 24 h the mixture was concentrated and 
the residue dissolved in EtOAc (600 mL) and washed with 10% citric acid, 4% NaHCO3, 
brine, dried (MgSO4), filtered and evaporated to get the alkylated diester.  
 This diester was dissolved in 1:1(v/v), mixture of ethanol and water (230 mL) at 0 C, and 
to this solution solid NaOH (7.0 g, 175 mmol) was added, this solution was then refluxed. 
After 24h the ethanol was removed and the resulting solution was dissolved in 4% NaHCO3 
and extracted with diethyl ether to remove the unreacted starting material. Then the 
remaining alkaline aqueous solution was acidified to pH ~ 3 with 1M HCl and extracted with 
EtOAc (20 mL × 20). The combined organic layer was washed with brine, dried (MgSO4), 
filtered and evaporated to give (RS)-6 as a white powder (15 g, 47 % w.r.t. 5). mp 119-121 C 
[lit.22 106-108 C]; 1H NMR (400 MHz, CD3OD) 5.89-5.79 (m, 1H), 5.10-5.00 (m, 2H), 4.37 
(m, 1H),  2.14 (m, 2H), 1.99 (s, 3H), 1.96-1.71 (m, 2H); 13C NMR (125 MHz, CD3OD) 175.6, 
173.5, 138.5, 116.2, 53.3, 32.1, 31.2, 22.5; LRMS-FAB (m/z) 343 (67), 194 (58), 172 (100), 
126 (68), 83 (68); HRMS-FAB (m/z) calcd for C8H14N1O3 ([M+H]+)172.0974  found 
172.0909.  
 
 (S)-2-amino-5-hexenoic acid (S)-7 and (R)-2-(acetamido)-5-hexenoic acid (R)-6. (RS)-6 
(3.00 g, 17.5 mmol) and CoCl2•6H2O (14 mg, 50 μmol) was dissolved in 60 mL of H2O at 38 
C, while maintaining pH at 7.5 with aqueous LiOH. L-aminoacylase  from Aspergillus 
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genus (0.8 g) was then added and stirred. The pH was monitored at 7.5 with small 
amount of NH4OH (1M). After 24 h, the reaction mixture was concentrated, acidified 
to pH ~ 2-3 with 1M HCl. The unreacted (R)-6 was extracted with EtOAc, washed 
with brine, dried (MgSO4), filtered and evaporated to give (R)-4.13 (1.23 g, 41%). 
(Column II. ee 88%). 
 The remaining acidic aqueous phase was applied to a column of ion exchange resin 
(DOWEX 50WX8). After sample charging and elution with 1M HCl, followed by 
H2O, finally compound (S)-4.14 was eluted with 1M NH4OH. Evaporation of this 
eluant afforded (S)-7 as white solid (0.72g, 32 %). (after N acetylation, Column II. ee > 
99%) 1H NMR (D2O, 500 MHz) 5.84-5.76 (m, 1H), 5.12-5.03 (m, 2H), 3.72-3.69 (m, 
1H), 2.15-2.11 (m, 2H), 1.99-1.85 (m, 2H); 13C NMR (D2O, 125 MHz) 174.7, 137.0, 
115.9, 54.3, 29.7, 28.6; LRMS-FAB (m/z) 130 (100). 
 
Kinetic resolutions by -chymotrypsin.  
 
(RS)-Ethyl 2-N-(tert-butoxycarbonyl)-2-amino-5-hexenoate (RS)-9.  Metallic 
sodium (0.92 g, 39.9 mmol) was added to EtOH (17.0 mL) at 0 C and stirred until 
complete dissolution of sodium. 8 (10.0 g, 36.3 mmol) was then added at the same 
temperature and stirred for 30 min. Finally 4-bromo-1-butene (5.6 mL, 54.8 mmol) 
was added in one portion and the resulting yellow solution was refluxed for 24 h. After 
24 h, the solution was partitioned between H2O and EtOAc, extracting the desired 
product into EtOAc. The EtOAc was then washed with 10% citric acid, brine, dried 
(MgSO4), filtered and evaporated to obtain an oil (9.51 g), which was suspended in 
EtOH:H2O (18:8, v/v) and cooled to 0 C. This solution was treated with solid 
LiOH.H2O (1.33 g, 31.8 mmol) and stirred overnight at 0 C. The solution was then 
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mixed with 4% NaHCO3 to make the solution alkaline and extracted with diethyl ether 
to remove any unreacted starting material. The remaining alkaline solution was then 
acidified to pH ~ 3 with solid citric acid and extracted with EtOAc. The EtOAc was 
then washed with brine, dried (MgSO4), filtered and evaporated to give the mono ester 
mono acid (8.30 g). This was dissolved in toluene (25 mL) and refluxed. After 18 h 
the solvent was evaporated at 40-50 C to give a crude mixture which directly purified 
by silica gel column chromatography (hexane:EtOAc, 80:20, v/v) to give (RS)-9 (5.5 
g, 59%, after 3 steps). 1H NMR (500 MHz, CDCl3) 5.84-5.76 (m, 1H), 5.07-5.00 (m, 
2H), 4.31-4.30 (m, 1H), 4.21 (m, 2H), 2.15-2.09 (m, 2H), 1.95-1.88 (m, 1H), 1,75- 
1.68 (m,1H), 1.45 (s, 9H) 1.28 (m, 3H); 13C NMR (125 MHz, CDCl3) 172.8, 155.3, 
137.1, 115.6, 79.8, 61.3, 53.1, 32.1, 29.5, 28.3, 14.2; LRMS-FAB (m/z) 258 (50), 230 
(21), 202 (100), 158 (93) and 128(18); HRMS-FAB (m/z) calcd for C13H24 N1O4 
([M+H]+) 258.1705, found 258.1707. 
 
 (R) ethyl 2-N-(tert-butoxycarbonyl)-2-amino-5-hexenoate (R)-9 and (S) 2-N-(tert-
butoxycarbonyl)-2-amino-5-hexenoic acid (S)-10. (RS)-9  (4.80 g, 18.6 mmol) was 
suspended in phosphate buffer ( 360 mL, 0.1 M; pH 8.00), warmed to 38 C and α-
chymotrypsin (28 mg, 40 units/mg) was added in one portion. The resulting mixture was 
stirred at 38 C for 24 h while monitoring the pH~8 with little amount of (1M NH4OH). After 
24 h the above solution was made more alkaline by addition of 4% NaHCO3 and was 
extracted with EtOAc (20 ml × 10). The combined EtOAc layer (200 mL)  was washed with 
brine, dried (MgSO4), filtered and evaporated to give (R)-9 ( 2.42 g, 51 %). (Column I. ee > 
64%); [α]D25 = - 9.30 (c = 2.44, CH2Cl2). The remaining alkaline solution was then acidified 
to pH~3, with solid citric acid and extracted with EtOAc (30 ml × 10). The combined EtOAc 
layer (300 mL) was washed with brine, dried (MgSO4), filtered and evaporated to give (S)-10 
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(1.95 g, 46 %). (Column I. ee > 99%); [α]D20 = - 1.18 (c = 1.30, CH3OH). {lit.23[α]D20 = - 
1.1 (c = 1.30, CH3OH)}; 1H NMR (500 MHz, CD3OD) 5.81-5.73 (m, 1H), 5.01-4.98 (m, 
3H), 4.04-4.02 (m, 1H), 2.18-2.08 (m, 2H), 1.91-1.85 (m, 1H), 1.75-1.68 (m, 1H), 1.44 (s, 
9H); 13C NMR (125 MHz, CD3OD) 175.0, 156.7, 137.1, 114.6, 79.1, 52.9, 30.8, 29.7, 27.3; 
LRMS-FAB (m/z) 275 (35), 252 (16), 230 (17), 174 (100) 130 (65); HRMS-FAB (m/z) calcd 
for C11H20N1O4 ([M+H]+) 230.1392, found 230.1336. 
 
m-CPBA oxidation 
(S) ethyl 2-N-(tert-butoxycarbonyl)-2-amino-5-hexenoate (S)-9. (S)-10 (1.31 g, 5.72 
mmol) was dissolved in DMF (15 mL) and cooled with an ice-water bath. This solution was 
treated with triethylamine (1.20 mL, 8.58 mmol) and finally ethyl bromide (2.6 mL, 35 
mmol). The resulting solution was then allowed to attain room temperature and continued to 
stir. After 24 h the solution was concentrated to get a crude mixture as an oil. This crude 
mixture was purified by silica gel column chromatography (hexane:EtOAc, 80:20, v/v) to 
give (S)-9 (1.24 g, 84 %). [α]D25 = + 8.53 (c = 2.46, CH2Cl2). [1H NMR same as (RS)-9]. 
 ethyl 2-[(tert-butoxycarbonyl)amino]-4-(2-oxiranyl)butanoate, (2S,5R)-11 and 
(2S,5S)-11. (S)-9 (1.2 g, 4.67 mmol) was dissolved in DCM 20.0 mL and cooled to 0 C with 
ice-water bath. To this solution m-CPBA (1.57 g, 7.0 mmol) was added in one portion and 
stirred. The ice-water bath was removed once the m-CPBA completely dissolved and allowed 
to stir at room temperature. After 24 h the crude reaction mixture was again cooled with in an 
ice-water bath, treated with 10% aqueous Na2SO3 (30 mL), then the solution was stirred 
vigorously to reduce the excess m-CPBA. After 2h the organic phase was separated and 
washed with 4% NaHCO3, brine, dried(MgSO4), filtered and evaporated to get a clear oil. 
This was purified by silica gel column chromatography (hexane:EtOAc, 70:30, v/v) to get 
pure 11 as a clear oil (1.15 g, 90 %). 1H NMR (500 MHz, CDCl3) 5.10-5.05 ( m, 1H), 4.32 (m, 
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1H)  4.20 (q, 2H), 2.93 (m, 1H), 2.76 (m, 1H), 2.49 (m, 1H,) 1.99 (m, 1H) 1.8 (m, 1H), 1.68 
(m, 1H) 1.51 (m, 1H), 1.45 (s, 9H, Boc), 1.29 (t, 3H); 13C NMR (125 MHz, CDCl3) 172.5 
(172.4), 155.4, 79.9, 61.5 (61.4), 53.2 (53.0), 51.6 (51.5), 47.1 (47.0), 29.2, 28.4, 28.3, 
14.2(14.1); LRMS-FAB (m/z) 274 (42), 218 (100), 174 (49); HRMS-FAB (m/z) calcd for 
C13H24N1O5 ([M+H]+) 274.1654, found 274.2659. 
 
Jacobsen’s Hydrolytic Kinetic Resolution (HKR). 
 
ethyl 2-[(tert-butoxycarbonyl) amino]-4-(2-oxiranyl)butanoate (2S,5R)-11 and ethyl 2-
[(tert-butoxycarbonyl) amino]-5,6-dihydroxyhexanoate, (2S,5S)-12. 11 (1 g, 3.65 mmol) 
was taken in a vial equipped with a stir bar, to this was added (RR)-Co-Salen (0.5 mol %, 12 
mg), followed by acetic acid (30 μL) and THF (0.3 mL). Finally H2O (2 mmol, 36 μL) was 
added in one portion at room temperature and stirred. After 48 h, the solution was directly 
purified by silica gel column chromatography, eluting the column by (EtOAc:hexane, 30:70, 
v/v) gave (2S,5R)-12 (0.47 g, 47 %) as a clear oil. Further elution with 
(EtOAc:haxane:methanol, 60:40:2, v/v/v) gave (2S,5S)-13 (0.49 g, 46 % ). 1H (500 MHz, 
CDCl3) 5.25-5.14 (m, 0.66H), 4.36 (m, 0.73H), 4.21 (q, 2H), 3.75 (br s, 0.91H), 3.64 (br s, 
0.96H), 3.46 (m, 0.98H), 2.03-1.93(m, 1.90H), 1.84-1.68 (m, 0.82H), 1.60-1.48 (m, 5H), 1.45, 
1.44 (both s, total 9H) 1.29 (t, 3H); 13C NMR (125 MHz, CDCl3) 173.0 (172.8), 155.8, 80.0 
(79.9), 71.7 (71.5), 66.6, (66.5), 61.4,  53.4, 29.0, 28.7, 28.3, 14.1;  LRMS-FAB (m/z) 356 
(33), 354 (35), 300 (53), 298 (55), 256 (98), 254 (100); HRMS-FAB (m/z) calcd for 
C13H26N1O6 ([M+H]+) 292.1760, found 292.1767. 
 
Synthesis of 5-hydroxypipecolic acid derivatives. (Scheme 9) 
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ethyl 2-[(tert-butoxycarbonyl) amino]-5-hydroxy-6-bromohexanoate (2S,5R)-13. 11 (0.46 
g, 1.71 mmol)  was dissolved in THF (15 mL) and cooled to 0 C. To this solution AcOH 
(0.30 mL, 5.25 mmol) was added followed by LiBr (0.24 g, 2.76 mmol). The solution was 
then warmed to room temperature and stirred.  After 16h, when the TLC analysis showed the 
complete disappearance of the epoxide, the solution was concentrated in vacuum and the 
residue taken in EtOAc. Washed with 4% NaHCO3, brine, dried( MgSO4), filtered and 
evaporated to get crude product which was purified by silica gel column chromatography 
eluting with (EtOAc:hexane, 40:60 v/v) to get 13 (0.55 g, 92 %).  1H NMR (500 MHz, 
CDCl3) 5.21 (bd, 1H), 4.37 (m, 1H), 4.21 (m, 2H), 3.82 (br s, 1H), 3.50-3.38 (m, 2H), 2.87 
(bd, 1H), 2.05-1.91 (m, 1H), 1.86-1.54 (m, 3H), 1.45 (s, 9H), 1.29 (t, 3H);  13C NMR (125 
MHz, CDCl3), 172.5, 155.7, 80.2, 70.8, 61.5, 53.1, 40.1, 30.6, 29.7, 28.3, 14.2; LRMS-FAB 
(m/z) 356 (33), 354 (35), 300 (53), 298 (55), 256 (98), 254 (100); HRMS-FAB (m/z) calcd for 
C13H25N1O5Br1 ([M+H]+) 354.0916, found 354.0881. 
 1-tert-butyl 2-ethyl 5-hydroxypiperidine-1,2-dicarboxylate (2S,5R)-16. 13 (0.26 g, 
0.73 mmol) was dissolved in TFA (5 ml) and allowed to stand at room temperature. Ater 1 h 
when the reaction was complete (TLC) the excess TFA was evaporated. The crude product 
was redissolved in diethyl ether and evaporated to remove excess TFA, to get 14.TFA as a 
white sticky oil. 
 14.TFA was dissolved in THF (5 mL) and to this DIEA (0.25 mL, 1.46 mmol) was 
added, and the resulting solution was stirred at room temperature. After 4h the solution was 
treated with additional DIEA (0.13 mL, 0.73 mmol) and Boc2O ( 0.32 g, 1.46 mmol). The 
resulting solution stirred at room temperature. After 12 h the solution was concentrated and 
the residue was dissolved in ethyl acetate and washed with 4% NaHCO3, 10% citric acid, 
brine, dried (MgSO4), filtered and evaporated to get an oil purified by silica gel column 
chromatography (EtOAc:hexane, 50:50, v/v) to get 16 as an oil (0.16 g, 80%). 1H (500 MHz, 
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CDCl3) 4.91, 4.74 (both br s, 1H), 4.20 (m, 2H), 4.08-3.95 (m, 2H), 3.24-3.10 (m, 1H), 2.17-
2.00 (m, 2H), 1.89-1.76 (m, 2H), 1.47, 1.45 ( both s, total 9H); 13C (125 MHz, CDCl3) 171.7 
(171.5), 156.5 (156.2), 80.4, 61.1, 54.7 (53.5), 48.1 (47.1), 28.2, 27.2 (26.9), 20.3, 14.3; 
LRMS-FAB (m/z) 274 (57), 218 (100), 174 (100), 144 (50); HRMS-FAB (m/z) calcd. for 
C13H24 N1O5 ([M+H]+) 274.1654, found 274.1656. 
 
Synthesis of (2S,5S) 5-hydroxypipecolic acid derivatives. (Scheme 10) 
 
ethyl 2-[(tert-butoxycarbonyl)amino]-5-hydroxy-6-tosylhexanoate (2S,5S)-17. 12 ( 0.45 g, 
1.53 mmol) was dissolved in DCM (25.0 mL) and cooled to -10 C, to this stirred solution 
triethylamine (0.25 mL, 1.8 mmol) followed by Bu2SnO (0.11 g, 0.46 mmol, 30 mol%) and 
DMAP (10 mg, cat.) were added. The solution was then stirred for 15 min at -10 C finally 
TsCl (0.32 g, 1.68 mmol) was added portion wise over a period of 1 h. The resulting solution 
was stirred for an additional 1 h. At the end of 2h, the reaction was quenched with 4% 
NaHCO3 and DCM was replaced with EtOAc. The EtOAc layer was washed with brine, 
dried(MgSO4), filtered and evaporated to give a crude mixture purified by silica gel column 
chromatography (EtOAc:hexane, 30:70 to 50:50, v/v) to give 17 (0.67 g, 97 %). 1H (500 
MHz, CDCl3) 7.80 (d, J = 8.3 Hz, 2H), 7.36 (d, J = 8.1 Hz, 2H), 5.10 (br d, 1H), 4.27 (m, 1H), 
4.19 (m, 2H), 4.12 (m, 1H), 4.00 (m, 1H), 3.88 (m, 2H), 2.46 (s, 3H), 1.91-1.77 (m, 2H), 
1.55-1.46 (m, 2H), 1.43 (s, 9H); 13C (125 MHz, CDCl3) 172.5, 155.5, 145.1, 132.6, 130.0, 
128.0, 80.0, 73.7, 68.8, 61.5, 53.0, 28.7, 28.3, 21.7, 14.2;  LRMS-FAB (m/z) 446 (15), 390 
(42), 347 (37), 346 (100); HRMS-FAB (m/z) calcd for C20H32 N1O8S1 ([M+H]+) 446.1849, 
found 446.1864. 
 ethyl 2-[(tert-butoxycarbonyl)amino]-5-hydroxy-6-iodohexanoate (2S,5S)-18.  17 
(0.55 g, 1.23 mmol) was dissloved in acetone (30 mL) and to this solution NaI (1 g, 6.67 
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mmol) was added and the resulting solution was refluxed for 8 h. After 8 h, the acetone was 
replaced with EtOAc and washed with sat.Na2S2O3, brine, dried (MgSO4), filtered and 
evaporated to give an oil purified by silica gel chromatography (EtOAc:hexane, 50:50, v/v) to 
give 18 (0.47 g, 95 %). 1H (500 MHz, CDCl3) 5.11 (bd, 1H), 4.32 (m, 1H), 4.21 (m, 2H), 3.58 
(m, 1H), 3.36 (m, 1H), 3.22 (m, 1H), 2.16 (bd, 1H), 1.93-1.92 (m, 1H), 1.82-1.80 (m, 1H), 
1.70-1.66 (m,1H), 1.60-1.53 (m, 1H),  1.45 (s, 9H), 1.28 (m, 3H); 13C NMR (125 MHz, 
CDCl3) 172.5, 155.5, 80.1, 70.3, 61.5, 53.1, 32.1, 29,1, 28.3, 15.8, 14.2; LRMS-FAB (m/z) 
402 (35), 346 (69), 302 (100), 284 (37); HRMS-FAB (m/z) calcd for C13H25N1O5I1 ([M+H]+) 
402.0777, found 402.0794. 
1-tert-butyl 2-ethyl 5-hydroxypiperidine-1,2-dicarboxylate (2S,5R)-19. 18 (0.262 g, 0.65 
mmol) was dissolved in TFA (4 ml) and allowed to stand at room temperature. After 1 h when 
the reaction was complete (TLC) the excess TFA was evaporated, the crude product was 
redissolved in diethyl ether and evaporated to remove excess TFA, to obtain Boc deprotected 
product as a salt of TFA, which was dissolved in THF (5 mL) and to this DIEA (0.23 mL, 
1.30 mmol) was added, and the resulting solution was stirred at room temperature. After 4h 
when the reaction was complete which was confirmed by TLC, the solution was treated with 
additional DIEA (0.12 mL, 0.65 mmol) and Boc2O (0.28 g, 1.30 mmol) and the resulting 
solution stirred at room temperature. After 12 h the solution was concentrated and the residue 
was dissolved in ethyl acetate and washed with 4% NaHCO3, 10% citric acid, brine, dried 
(MgSO4), filtered and evaporated to get an oil purified by silica gel column chromatography 
(EtOAc:hexane, 50:50, v/v) to get 19 as an oil (0.13 g, 76 %). 1H NMR (500 MHz, CDCl3) 
4.87-4.58 (m, 1H), 4.28-4.04 (m, 3H), 3.71-3.58 (m, 1H), 2.82-2.64 (m, 1H), 2.35-2.19 (m, 
1H) 2.04-1.94 (m, 1H), 1.78-1.67 (m, 1H), 1.62-1.53 (m, 1H), 1.47, 1.44 (both s, total 9H); 
13C NMR (125 MHz, CDCl3) 171.5 (171.4), 155.5 (155.2), 80.5, 66.8 (66.7), 61.3, 54.0 
(52.8), 48.5 (47.6), 30.5 (30.0), 28.3, 25.0 (24.8), 14.2;  LRMS-FAB (m/z) 274 (70), 218 (60), 
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174 (100), 144 (45); HRMS-FAB (m/z) calcd for C13H24 N1O5 ([M+H]+) 274.1654, found 
274.1658. 
 
4. Conclusion 
 
Starting from a common intermediate all the four isomers of 5-hydroxypipecolic acid 
(2S,5R)-, (2S,5S)-, (2R,5S)- and (2R,5R) were synthesized from commercially 
available malonate derivatives. Enatiomerically pure 2-amino-5-hexenoic acids were 
obtained by enzymatic resolution of the racemic amino acid ester (-chymotrypsin) or 
acetyl aminoacid (L-acylase). Oxidation of the unsaturated side chain of the 
enatiomerically pure L-2-amino-5-hexenoic acid with m-CPBA, generated the 
diastereomeric, inseparable epoxides. Co catalysed hydrolytic kinetic resolution 
converted the diastereomeric epoxide into separable components, which were 
correspondingly transformed into C6 halo amino acids. Followed by, intramolecular 
nucleophilic attack of the amino -NH2 group at C6 carbon generating the respective 5-
hydroxypipecolic acid diastereomers. Similarly starting from D-2-amino-5-hexenoic 
acid two diastereomers of 5-hydroxypipecolic acid were synthesized. Ultimately a 
single diastereomer was successfully achieved surpassing the difficulty of isolation of 
the cis- and trans- diastereomers in a facile fashion. 
 
 
 
 
 
76 
 
5. References 
 
(1a) P. N. M. Botman, F. J. Dommerholt, R. de. Gelder, Q. B. Broxterman, H. E. Schoemaker, 
F. P. J. T. Rutjes and R. H. Blaauw, Org. Lett. 2004, 6, 4941-4944. 
(2) C. Klein and W. Huttel, Adv. Synth. Catal. 2011, 353, 1375–1383. 
(3) R. Haraa, N. Uchiumib and K. Kino, Journal of Biotechnology 172 (2014) 55– 58 
(4) K. Koketsu, Y. Shomura, K. Moriwaki, M. Hayashi, S. Mitsuhashi, R. Hara, K. Kino and 
Y. Higuchi, ACS Synth. Biol. 2015, 4, 383−392. 
(5) T. Shibasaki, W. Sakurai, A. Hasegawa, Y. Uosaki, H. Mori, M. Yoshida and A. Ozaki, 
Tetrahedron Lett. 1999, 40, 5227–5230. 
(6) S. Krishnamurthy, T. Arai, K. Nakanishi and N. Nishino, RSC Adv., 2014, 4, 2482–2490. 
(7) B. Witkop and C. M. Foltz, J. Am. Chem. Soc., 1957, 79, 192-197. 
(8) S. Hoarau, J. L. Fauchère, L. Pappalardo, M. L. Roumestant and P. Viallefont, 
Tetrahedron: Asymmetry, 1996, 7, 2585–2593. 
(9) D. S. Kemp and T. P. Curran, J. Org. Chem., 1986, 51, 2377–2378. 
(10) J. E. Baldwin, C. Hulme and C. J. Schofield, J. Chem. Res. (M), 1992, 1517-1526. 
(11) P Allevi, M. Galligani and M. Anastasia, Tetrahedron: Asymmetry, 2002, 13, 
1901–1910. 
(12) S. E. Schaus, B. D. Brandes, J. F. Larrow, M. Tokunaga, K. B. Hansen, A. E. 
Gould, M. E. Furrow and E. N. Jacobsen J. Am. Chem. Soc., 2002, 124, 1307–1315. 
(13) M. Tokunaga, J. F. Larrow, F. Kakiuchi and E. N. Jacobsen, Science, 1997, 277, 
936-938. 
(14) J. S. Bajwa and R. C. Anderson, Tetrahedron Lett., 1991, 32, 3021-3024. 
(15) D. Scarpi, L. Bartali, A Casini and E. G. Occhiato, Eur. J. Org. Chem. 2013, 2013 1306–
1317. 
77 
 
(16) 1.HCl m.p. 215-217, [α]D23 = -10.8 (c = 0.6, H2O), {lit.1 212-215 C; lit.15 [α]D23 = - 
9.5 (c = 0.59, H2O)}. 
(17) R. B. Kamble, S. H. Gadre and G. M. Suryavanshi, Tetrahedron Lett., 2015, 56, 
1263–1265. 
(18) M. J. Martinelli, N. K. Nayyar, E. D. Moher, U. P. Dhokte, J. M. Pawlak and R. 
Vaidyanathan, Org. Lett. 1999, 1, 447-450. 
(19) For selective mono mesylation see: J. Marin, C. Didierjean, A. Aubry, J.-P. Briand 
and G. Guichard, J. Org. Chem. 2002, 67, 8440-8449. 
(20) m.p. 188-192 C, [α]D20 = -23.1 (c = 1, H2O), {lit.28 m.p. 195-196 C; [α]D20 = - 21.9 
(c = 1, H2O)}. 
(21) C. Herdeis and E. Heller, Tetrahedron Lett., 1993, 4, 2085-2094. 
(22) Y. A. Lin, J. M. Chalker, N. Floyd, G. J. L. Bernardes and B. G. Davis, J. Am. 
Chem. Soc., 2008, 130, 9642–9643. 
(23) K. Ramesh, S. Surprenant and W. D. Lubell, J. Org. Chem. 2005, 70, 3838-3844. 
(24) S. Krishnamurthy, V. Jalli, T. C. Vagvala, T. Moriguchi and A. Tsuge, RSC Adv., 2015, 5, 
52154–52160. 
 
 
 
 
 
 
 
 
 
 
 
 
 
78 
 
Chapter 5 
 
 
Regioselective cyclization and facile separation of 
5-hydroxypipecolic acid and Crystal structure 
analysis 
 
1. Introduction 
 
In the last six decades there are multiple reports on the synthesis of 5-hydroxypipecolic acid, 
including intramolecular cyclization of the epoxide derived from 2-amino-5-hexenoic acid 
(Scheme 1).1-3 Unfortunately all the reports that describe the synthesis of 5-hydroxpipecolic 
acid from intramolecular cyclization of epoxide, generate the cis- and trans- diastereomers of 
5-hydroxypipecolic acid (5.2-5.3). The separation of the cis- and trans- diastereomers are 
difficult as described earlier. Additionally a serious draw back in these reaction is the 
formation of unwanted regio-isomeric 5-hydroxymethyl proline diastereomers (5.4-5.5) 
(Scheme 1). Therefore this reaction in total gives rise to formation of 4-cyclic amino acids, 
whose isolation is very tedious and time consuming and the yields of 5-hydroxypipecolic acid 
generated were very low.  
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Scheme 1) Intramolecular cyclization of epoxide derived from 2-amino-5-hexenoic acid 
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For instance Witkop and Foltz,1 tried the synthesis of 5-hydroxypipecolcic acid by 
intramolecular cyclization in presence of base. The formide derivative of 2-amino-5-hexenoic 
acid (5.6), was cyclized to pipecolic acid at 37 C for 72 h. But the major product obtained 
was 5-hydroxmethylproline (5.7). The 5-hydroxypipecolic acid (5.8), were obtained in a very 
low yield (Scheme 2). 
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Scheme 2) Intramolecular cyclization in basic condition. 
 
Similarly Kemp and Curran,2 tried the synthesis of 5-hydroxypipecolic acid by intramolecular 
cyclization of similar epoxide. 5.9 was subjected to catalytic hydrogenolysis which cleaved 
the (Cbz), and generated free amine which attacks the epoxide to generate the cyclic amino 
acids. But again the major product obtained was 5-hydroxmethylproline (5.10) with little 5-
hyroxypipecolic acid (5.11), were obtained in a very low yield (Scheme 3). 
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Scheme 3) Intramolecular cyclization in basic condition. 
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 Hence an easy procedure to isolate this rare amino acid as well as exclusive formation 
of piperidine ring is necessary. We would like to describe in this synthesis, an easy procedure 
for isolating the 5-hydroxypipecoloic acid exclusively. Although the yield were moderate we 
were able to synthesize all the four isomers of 5-hydroxypipecolic acid. Further this is the 
first study wherein we were able to isolate crystals and study the crystal structure of 5-
hydroxypipecolic acid. 
 
2. Results and Discussion. 
  
Synthesis of enatiomerically pure 2-amino-5-hexenoic acid (Scheme 4). 
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Scheme 4) Synthesis of enatiomerically pure 2-amino-5-hexenoic acid. 
 
5.12 was treated with excess 4-bromo-1-butene in presence of sodium ethoxide to 
obtain the alkylated diester. The later was selectively saponified with NaOH (1M) to 
obtain the half acid half ester, which was successfully decarboxylated in refluxing 
toluene to obtain DL-5.13 (57 % overall yield with respect to 5.12).  
 A solution of DL-5.13 in H2O/DMF (3:1, v/v) at 38 C, with pH 8 was treated with 
subtilisin Carlsberg from (Bacillus licheniformis). The pH which decreased due to the 
formation of L-5.14, was adjusted to pH 8, by continuous addition of NH4OH. After 
5h the mixture was concentrated, dissolved in alkaline aqueous solution 4% NaHCO3, 
followed by diethyl ether extraction to remove the unreacted D-5.13 obtained in (51 % 
yield). The alkaline aqueous solution was then acidified with solid citric acid to pH 3, 
extracted with EtOAc to obtain L-5.14 (49% yield). These isolated amino acids were 
of high chemically purity (1H NMR) and specific rotation data matched the reported 
values. 
A solution of D-5.134 in DCM, was treated with excess m-CPBA at 0C, followed by 
stirring at room temperature for 24 h. The DCM was then replaced with EtOAc, and 
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excess m-CPBA was carefully reduced with 10% Na2SO3 at 0C. The EtOAc layer 
was separated washed (4% NaHCO3 and brine), concentrated and chromatographed 
(SiO2) to obtain 5.15 (88%). The epoxide was generated as a diastereomeric mixture 
due to the newly generated chiral centre at C5 carbon. But these diastereomers were 
not separable. 
 
 
CO2EtBocHN
D-5.13
m-CPBA
DCM
88%
CO2EtBocHN
O
5.15
diastereomers
     not 
separable
 
                                    
Scheme 5) m-CPBA oxidation of D-5.13 
  
tert-butoxycarbonyl (Boc) removal and intramolecular cyclization (Scheme 6). 
A solution of 5.15 in 1,4-dioxane at 0 C, was treated with 4 mol/L HCl in 1,4-
dioxane. After 3 h, the solution was concentrated to obtain 5.16.HCl in quantitative 
yield. 5.16.HCl, was dissolved in DMF at 0C, and treated with triethylamine and 
stirred. On treating with triethylamine it leads to the neutralization of HCl and 
liberation of free amine group (5.17). 
This amine group will attack the epoxide side chain intramolecularly. TLC analysis at 
the end of 24 h, (butanol/pyridine/acetic acid/H2O, 4:1:1:2. v/v/v/v) still showed the 
presence of the reactant. After 72 h of stirring at room temperature, TLC analysis 
showed the complete conversion of reactant, and ninhydrin analysis of the TLC 
showed the appearance of two new spots at an higher Rf value. This confirmed that the 
nitrogen intramolecularly attacked the epoxide side chain to produce cyclic amino 
acids. The DMF was removed in vacuum and replaced with 1,4-dioxane, the nitrogen 
of the amino acid was again reprotected  with Boc group by treatment with Boc2O in 
presence of triethylamine  to generate the Boc-5-hydroxypipecolic acid derivatives. 
The fully protected amino acid were separated after work up by silica gel column 
chromatography (CHCl3:MeOH, 100:0 to 98:2, v/v). 
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Scheme 6. Boc removal and intramolecular cyclization. 
 
 The first eluted product was an unknown hydrophobic solid cis-5.22 (Scheme 6), 
and not the expected cis-5.20. The 1H NMR for cis-5.22 showed the absence of ethyl 
group and it was further supported by FAB-MS analysis which showed the peak for 
the molecular ion (M+H+ = 228). But to our satisfaction the second eluted product was 
5-hydroxypipecolic acid derivative, trans-5.21 (1H NMR matched the reported 
values). 
N
CO
O
Boc
cis-5.22
N
O
O
Boc
cis-5.23
2 possible structure for (M+H = 228)
Mol. Wt.: 227.3 Mol. Wt.: 227.3  
 
Figure 1) Two possible structure for M+H+ = 228 
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X-Ray analysis. 
A quick search in the SciFinder® gave no result for both cis-5.22 and cis-5.23, other than the 
N-tosyl derivative for cis-5.22. Hence in order to confirm the structure of the first eluted 
lactone (cis-5.22 or cis-5.23), a single crystal X-ray analysis was performed. By slow 
evaporation of a CH2Cl2/diethyl ether (1:1, v/v) solution of the lactone single crystals suitable 
for X-ray analysis were generated. 
 To our satisfaction, the X-ray analysis confirmed the structure to be 5-
hydroxypipecolic acid derivative (cis-5.22) (Figure 2).  The compound crystallizes in 
the space group P21/c. No intra- and intermolecular hydrogen bonds exist in the 
crystal. But unfortunately even though we started the reaction with enatiomerically 
pure reactant, we ended up getting a racemic mixture of the crystal (Figure 3). But to 
our satisfaction we did obtain pipecolic acid with no detectable amount of the 
pyrrolidine ring (cis-5.23). 
 
 
 
 
 
 
     
 
 
  
            
 
 
 
 
               Top view                                                                                          Side view                                                                   
 
Figure 2: Ortep view of cis-5.22, hydrogen atoms are omitted for clarity. One of two isomers 
is only shown (below, side and top view). Displacement ellipsoids are drawn at the 50% 
probability level. Blue and red ellipsoids show N and O atoms, respectively. 
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Figure 3: Crystal packing of cis-5.22. Blue and red ellipsoids show N and O atoms, 
respectively. 
 
tert-butoxycarbonyl (Boc) removal and intramolecular cyclization (Scheme 7) 
A solution of 5.15 in 1,4-dioxane at 0 C, was treated with 4 mol/L HCl in 1,4-
dioxane. After 3 h, the solution was concentrated to obtain an oil, which was 
precipitated by trituration with diethyl ether to give 5.16.HCl as a foam (100 %). 
 5.16.HCl, was dissolved in DMF and warmed to 50 C, and treated with DIEA (1.5 
eq) and continued to stir at 50 C. TLC analysis at the end of 6 h, showed the absence 
of the starting material. The solution was then cooled to room temperature and treated 
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with DIEA (1 eq), followed by Boc2O to reprotect the nitrogen. After 18 h the fully 
protected amino acids were purified by SiO2 (CHCl3:MeOH, 100:0 to 98:2, v/v). 
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Scheme 7. Boc removal and intramolecular cyclization in presence of DIEA. 
 
 The first eluted product was cis-5.22 similar to the earlier result. And the second 
eluted product was 5-hydroxypipecolic acid derivative, trans-5.21 (1H NMR matched 
the reported values). 
X-Ray analysis. 
In order to confirm the structure of the first eluted lactone (cis-5.22), a single crystal X-
ray analysis was performed. Single crystals were obtained by vapour diffusion method 
at room temperature, i.e., hexane vapour was allowed to diffuse into a EtOAc (0.5 ml) 
solution of 5.23 at room temperature. Single crystals suitable for analysis were 
obtained after a week. 
 To our satisfaction, the X-ray analysis confirmed the structure to be 5-
hydroxypipecolic acid derivative (cis-5.22) (Figure 4).  The compound crystallizes in 
the space group P212121. And the compound was enatiomerically pure, with only 
(R,R)- isomer in the crystal packing (Figure 5) Again we detected only the 5-
hydroxypipecolic acid derivatives in the crystal packing with no pyrrolidine ring (cis-
5.23). 
tert-butoxycarbonyl (Boc) removal and intramolecular cyclization. 
A solution of L-5.14 in DMF easily esterified with BnBr in presence of DIEA to get L-
5.24, an oil after purification (79%). A solution of L-5.24 in DCM, was treated with 
excess m-CPBA at 0C, followed by stirring at room temperature for 24 h. The DCM 
was then replaced with EtOAc, and excess m-CPBA was carefully reduced with 10% 
Na2SO3 at 0C. The EtOAc layer was separated and washed (4% NaHCO3 and brine), 
concentrated and chromatographed (SiO2) to obtain 5.25 (78%). A solution of 5.25 
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was treated with 4 mol/L HCl in 1,4-dioxane to remove the N-Boc protection. After 3 
h, the solution was concentrated to obtain an oil, which was precipitated by trituration 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Molecular view of (2R, 5R) cis-5.22. Displacement ellipsoids are drawn at the 50% 
probability level. The blue and red ellipsoids represent N and O atoms, respectively. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Crystal packing of (2R,5R) cis-5.22. the blue and red ellipsoids represent N and O 
atoms, respectively. All hydrogen atoms are omitted for clarity. 
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Scheme 8. Boc removal and intramolecular cyclization in presence of DIEA. 
 
with diethy ether to give 5.26.HCl as an oil (100 %). 5.26.HCl, was dissolved in DMF 
and warmed to 50 C, and treated with DIEA (1.5 eq) and continued to stir at 50 C. 
After 5 h, the solution was cooled to room temperature and treated with DIEA (1 eq), 
followed by Boc2O to reprotect the nitrogen. After 18 h the fully protected amino acid 
was passed through SiO2 to get a mixture of cis-5.22 and trans-5.27 as an oil (Scheme 
8). 
 The cis-5.22 and trans-5.27 as a mixture was dissolved in AcOH, in the presence of 
Pd-C (0.25 g). The resulting black solution was stirred under H2 gas for 6 h. After 6 h, 
the solution was separated from Pd-C catalyst, AcOH evaporated to give a crude oil. 
This oil was dissolved in 4% NaHCO3 (25 mL) and extracted with diethyl ether. The 
hydrophobic cis-5.22 was easily separated as a solid from the acidic trans-5.28 which 
remain in the alkaline NaHCO3 solution by simple extraction with diethyl ether. Next 
the remaining aqueous solution was acidified to pH ~ 3, with solid citric acid. The 
acidic solution was extracted with EtOAc which after work up gave trans-5.28. The 
Boc group of trans-5.28 was removed by treating with 4 mol/L HCl in 1,4-dioxane to 
get trans-5.29. The spectral data and specific rotation measurement matched the 
reported data. 
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X-Ray analysis. 
In order to confirm the structure lactone (cis-5.22), a single crystal X-ray analysis was 
performed. Single crystals were obtained by vapour diffusion method at room 
temperature, i.e., hexane vapour was allowed to diffuse into a EtOAc (0.5 ml) solution 
of cis-5.22 at room temperature. Single crystals suitable for analysis were obtained 
after a week. 
 To our satisfaction, the X-ray analysis confirmed the structure to be 5-
hydroxypipecolic acid derivative (cis-5.22) (Figure 6).  The compound crystallizes in 
the space group P212121. And the compound was enatiomerically pure, with only 
(S,S)-isomer in the crystal packing (Figure 7). Again we detected only the 5-
hydroxypipecolic acid derivatives in the crystal packing with no pyrrolidine ring. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   Top view                                                                                           Side View 
Figure 6: Molecular view of (2S,5S)-cis-5.22. Displacement ellipsoids are drawn at the 50% 
probability level. The blue and red ellipsoids represent N and O atoms, respectively. 
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Figure 7. Crystal packing of (2S,5S)-cis-5.22. the blue and red ellipsoids represent N and O 
atoms, respectively. All hydrogen atoms are omitted for clarity. 
 
3. Experimental. 
Kinetic Resolutions of 2-amino-5-hexenoic acid derivative by subtilisin Carlsberg from 
Bacillus liceniformis. (Scheme 2) 
Synthesis of DL-5.7. 
To a flask containing 100 mL of absolute ethanol with a sodium hydroxide guard tube, 
sodium metal (2.5 g) was added. After complete dissolution of sodium, 5.12 (25.9 mL, 100 
mmol) was added and the resulting mixture was refluxed. After 1h to this refluxing solution 
4-bromo-1-butene (13.5 g, 100 mmol) was added and the reflux was continued. After 8 h 
when the reaction was complete, which was confirmed by TLC, the mixture was cooled to 0 
C, and to this stirred solution 2M NaOH (60mL, 120 mmol) was added over a period of 1 h. 
After 3 h when the reaction was complete, the ethanol was removed under vacuum. The 
resulting solution was dissolved in 4% NaHCO3(aq) and extracted with diethyl ether to 
remove the unreacted starting material. This alkaline aqueous solution was then acidified to 
pH 3 with solid citric acid, and extracted with ethyl acetate to get half acid half ester as an oil. 
This was dissolved in 120 ml of toluene and refluxed for 8 h. Then the toluene was 
evaporated to get a crude mixture which was purified by silica gel column chromatography 
eluting with ethylacetate:hexane (30:70, v/v) to give DL-5.13 (13.5 g, 57 % based on 5.12).  
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1H NMR (500MHz, CDCl3) 5.84-5.76 (m, 1H), 5.07-5.00 (m, 2H), 4.31-4.30 (m, 1H), 4.21 
(m, 2H), 2.15-2.09 (m, 2H), 1.95-1.88 (m, 1H), 1,75- 1.68 (m,1H), 1.45 (s, 9H) 1.28 (m, 3H); 
13C NMR (125MHz, CDCl3) 172.8, 155.3, 137.1, 115.6, 79.8, 61.3, 53.1, 32.1, 29.5, 28.3, 
14.2; LRMS-FAB (m/z) 274 (13), 258 (50), 230 (21), 202 (100), 158 (93) and 128(18); 
HRMS-FAB (m/z) calcd for C13H24 N1O4 ([M+H]+) 258.1705, found 258.1707.  
Synthesis of (D-5.13) and (L-5.14). 
 DL-5.13 (10.2 g, 39.7 mmol) was dissolved in a mixture of DMF: H2O (40:120, v/v). This 
solution was warmed to 38C and subtilisin Carlsberg from Bacillus licheniformis (13 mg, 1 
mg enzyme per mmol of substrate) was added and stirred at 38C. The pH which decreased 
rapidly in the beginning, was maintained at 7–8 by continuous addition of 1 M NH4OH. The 
reaction was continued for 6 h and then concentrated in vaccum, the crude reaction mixture 
was then dissolved in 4% NaHCO3 and the unreacted D-5.13 was removed by extraction with 
diethyl ether under alkaline condition. The diethyl ether was washed with brine, dried over 
MgSO4, filtered and evaporated to get D-5.13 (5.20 g, 51 %). Then the alkaline NaHCO3 
solution was acidified to pH  3 with solid citric acid and extracted with EtOAc. The 
combine organic layer was washed with brine, dried (MgSO4), filtered and evaporated to get 
L-5.14 (5.0 g, 49 %). 1H NMR (500 MHz, CD3OD) 5.86-5.78 (m, 1H), 5.07-4.98 (m, 3H), 
4.09-4.06 (m, 1H), 2.18-2.08 (m, 2H), 1.91-1.85 (m, 1H), 1.75-1.68 (m, 1H), 1.44 (s, 9H); 
HRMS-FAB (m/z) calcd for C11H20N1O4 ([M+H]+) 230.1392, found 230.1336. 
Synthesis of (5.9).  
D-5.13 (4.5 g, 17.5 mmol) was dissolved in DCM 100.0 mL and cooled to 0 C with ice-
water bath. To this solution m-CPBA (6.0 g, 27.0 mmol) was added portion wise and stirred. 
The ice-water bath was removed once the m-CPBA completely dissolved and allowed to stir 
at room temperature. After 24 h the crude reaction mixture was again cooled with in an ice-
water bath, treated with 10% aqueous Na2SO3 (100 mL), then the solution was stirred 
vigorously to reduce the excess m-CPBA. After 2h the organic phase was separated and 
washed with 4% NaHCO3, brine, dried (MgSO4), filtered and evaporated to get a clear oil. 
This was purified by silica gel column chromatography (hexane:EtOAc, 70:30, v/v) to get 
pure 5.15 as a clear oil (4.20 g, 88 %). 1H NMR (500 MHz, CDCl3) 5.10-5.05 ( m, 1H), 4.32 
(m, 1H)  4.20 (q, 2H), 2.93 (m, 1H), 2.76 (m, 1H), 2.49 (m, 1H,) 1.99 (m, 1H) 1.8 (m, 1H), 
1.68 (m, 1H) 1.51 (m, 1H), 1.45 (s, 9H, Boc), 1.29 (t, 3H); LRMS-FAB (m/z) 274 (42), 218 
(100), 174 (49); HRMS-FAB (m/z) calcd for C13H24N1O5 ([M+H]+) 274.1654, found 
274.2659. 
91 
 
3.1. Synthesis of racemic cis-5.16 and trans-5.15 (Scheme 6). 
5.15 (3.22 g, 11.8 mmol) in 2.0 mL of 1,4-dioxane was added to the ice-cooled 
solution of HCl in 1,4-dioxane (4 mol/L, 16 mL), the solution was then warmed to 
room temperature and stirred. After 3 h, the volatile materials were removed to give 
5.16.HCl (quantitative) which was dried under vacuum overnight. 
5.16.HCl was then mixed with triethylamine (3.30 mL, 23.8 mmol) in dry DMF (48 
mL) and stirred for 72 h. Subsequently, the solvent was evaporated and the residue 
was redissolved in 100 mL 1,4-dioxane and Boc2O(3.96 g, 18.1 mmol) and 
triethylamine (1.06 mL, 14.5 mmol) were added and stirred at room temperature. After 
18 h the solution was concentrated and redissolved in EtOAc and washed with 10% 
citric acid, 4% NaHCO3, brine, dried(MgSO4) filtered and evaporated to give a crude 
mixture as an oil. Purification with (SiO2) with (CHCl3:MeOH, 100:0 to 98:2, v/v) 
afforded cis-5.22 as a solid (0.67 g, 25%) and trans-5.21 (0.8 g, 24%) (matched the 
reported data). 
cis-5.22- 1H NMR (500M Hz, CDCl3) 4.61-4.82 (m, 2H), 3.63 (m, 1H), 3.45 (m, 1H), 2.22 
(br s, 1H), 2.11 (m, 1H), 2.00 (m, 1H), 1.80 (m, 1H), 1.47 (s, 9H); LRMS-FAB (m/z) 228 (74), 
190 (44), 172 (100), 137 (50), 128 (68), 55 (47); HRMS (FAB) calcd for C11H18N1O4 [M + 
H]+ 228.12358, found 228.1243 
3.2 Synthesis of enatiomerically pure cis-5.16 and trans-5.15 (Scheme 7). 
To a ice cooled solution of 4 mol/L HCl in 1,4-dioxane (16 mL), a solution of diastereomeric 
5.15 (0.97 g, 3.56 mmol) in 0.5 mL of 1,4-dioxane was added. This reaction mixture was then 
warmed to room temperature and stirred. After 3 h most of the volatile materials were 
removed under vacuum resulting in a crude oily mixture. Trituration with diethyl ether 
followed by decantation resulted in 5.16.HCl as a foam (0.71 g, 95 %). 
DIEA (0.89 mL, 5.07 mmol) was added to a solution of 5.16.HCl (0.71 g, 3.38 mmol) in 
DMF (13 mL) and stirred at 50 °C. After 6 h the solution was warmed to room temperature, 
followed by addition of Boc2O (3.96 g, 18.1 mmol), additional DIEA (0.3 mL, 1.69 mmol) 
and stirred at room temperature for 18 h. The DMF was evaporated and the crude mixture 
was subsequently washed with 10% aqueous citric acid, 4% aqueous NaHCO3, brine, dried 
(MgSO4), filtered and evaporated to obatin an oil. The crude product was purified by silica 
gel column chromatography with (CHCl3/MeOH, 100:0 to 98:2, v/v) to yield cis-5.22 (0.18 g, 
23%) as a white solid and trans-5.21 (0.25 g, 26%). 
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3.3 Synthesis of enatiomerically pure cis-5.22 and trans-5.21 (Scheme 8). 
L-5.14 (5.4 g, 23.6 mmol) was dissolved in DMF 15.0 mL and cooled to 0 C with ice water 
bath. To this solution benzyl bromide (3.50 mL, 29.5 mmol) was added in one portion and 
then finally DIEA (4.16 mL, 30.1 mmol) was added. The solution was then warmed to room 
temperature and stirred. After 24 h the solution was concentrated and redissolved in EtOAc 
washed with citric acid, NaHCO3, dried (MgSO4), and evaporated to get a L-5.24 (5.95 g, 
79%). 1H NMR (500MHz, CDCl3) 7.38-7.33 (m, 5H), 5.80-5.72 (m, 1H), 5.22-4.97 (m, 4H), 
4.37 (m, 1H), 2.11-2.05 (m, 2H), 1.95-1.89 (m, 1H), 1.76-1.69 (m, 1H), 1.44(1.45) (both s, 
total 9H); LRMS-FAB (m/z) 320 (33), 264 (100), 220 (87), 91 (100);  HRMS-FAB (m/z) 
calcd for  C18H26N1O4 ([M+H]+), 320.1862 found 320.1850. 
L-5.24 (2.3 g, 7.20 mmol) was dissolved in DCM and cooled to 0 C with ice-water bath. To 
this cooled solution was added m-CPBA in one portion. The ice-water bath was removed 
once the m-CPBA completely dissolved, and this solution was allowed to stir at room 
temperature. After 24 h, the crude reaction mixture was carefully concentrated to dryness to 
obtain a white solid. This mixture was again dissolved in EtOAc at 0 C, and to this resulting 
solution 10 % aqueous Na2SO3 was added carefully and stirred vigorously to reduce the 
excess m-CPBA. After 2h the organic phase was separated and washed with NaHCO3, brine, 
dried(MgSO4), filtered and evaporated to get clear a oil, which was purified by silica gel 
column chromatography (hexane:EtOAc, 70:30, v/v) to get L-5.25 (1.85 g, 78 %) as an oil. 
1H NMR (500MHz, CDCl3) 7.38-7.33 (m, 5H), 5.22-5.13 (m, 2.72 H), 5.05 (m, 0.5H), 4.39 
(brs, 1H), 2.88(m, 1.17H), 2.73 (m, 1.21H), 2.43 (m, 1.20H), 2.00 (m, 2H), 1.99-1.64 (m, 2H), 
1.45 (s, 9H); LRMS-FAB (m/z) 336 (34), 280 (100), 236 (85), 218 (29); HRMS-FAB (m/z) 
calcd for C18H26N1O5 ([M+H]+) 336.1811, found 336.1804. 
 L-5.25 (0.83 g, 2.47 mmol) was dissolved in 2 mL of 1,4-dioxane, and added to a 
stirred solution of 4 mol/L HCl in 1,4-dioxane 16 mL. This resulting solution was allowed to 
attain room temperature and stirred. After 3 h the mixture was concentrated to get 5.26.HCl 
(91 %), which was dissolved in 40 mL of DMF, to this solution DIEA (0.65 mL, 3.72 mmol) 
was added and the resulting solution stirred at 50 C. After 6 h, when the reaction was 
complete the solution was warmed to room temperature and treated with Boc2O (1.08 g, 4.96 
mmol) and DIEA (0.33 mL, 1.86 mmol) was added and the resulting heterogeneous solution 
was stirred at room temperature. After 18 h, the solution was concentrated to a crude mixture 
which was dissolved in EtOAc and washed with 10% citric acid, 4% NaHCO3, brine, dried 
(MgSO4), filtered and evaporated to get a mixture as an yellow oil which was purified by 
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silica gel column chromatography by eluting with chloroform:methanol (98/2, v/v) to give a 
mixture of cis-5.22 and trans-5.27 (0.83 g) 
The mixture of cis-5.22 and trans-5.27 (0.83 g) obtained above was dissolved in 15 mL of 
acetic acid, and then Pd/C (10% w/w, 0.25 g) was added to the solution. The resulting black 
suspension was stirred for 6 h under a hydrogen gas stream. The suspension was then filtered, 
and the filtrate was concentrated to a colorless oil. Next, a solution of 4% NaHCO3 (aq) was 
added to the resulting residue, and the mixture was extracted with diethyl ether (20 mL × 3). 
The combined organic layers were washed with brine, dried over MgSO4, filtered, and 
evaporated under vacuum to give cis-5.22 (120 mg, 21%) as a white solid and trans-28 as a 
solid (0.15 g, 25 %). 
trans-28 was dissolved in 1,4-dioxane (1 mL) and added to a cooed solution of 4 mol/L HCl 
in 1,4-dioxane (5 mL) and stirred. After 3 h at room temperature the solution was 
concentrated to get trans-29 (quantitative). The spectral data of trans-29 matched the 
previous reported data. 
 
4. Conclusion 
 
In summary all the four stereoisomers of 5-hydroxypipecolic acid were synthesized. 
The enatiomerically pure 2-amino-5-hexenoic acid derivatives were synthesized from 
malonate derivatives with the aid of enzyme subtilisin Carlsberg. The alkene side 
chain was easily oxidized with m-CPBA to generate the diastereomeric mixture of the 
epoxide, due to the newly generated chiral centre at C5 carbon. These diastereomers 
were not separable confirming the earlier reports. This amino acids with side-chain 
epoxide groups were subjected to the nucleophilic attack of the -NH2 group on 
epoxide. Intramolecular reaction generated 5-hydroxypipecolic acid selectively with 
six membered ring. Due to diastereomeric nature of the starting epoxide two 
stereoisomers of 5-hydroxypipecolic acid were formed. But due to the presence of 
acidic condition the cis-5.20 was intramolecularly lactonized to cis-5.22. The 
separation of the cis-5.20 from the trans-5.22 was facile due to large difference in Rf. 
Cyclization in presence of triethylamine for 72 h at room temperature unfortunately 
gave the racemic crystals in spite of enatiomerically pure starting material. 
Subsequently the cyclization was carried out with bulkier base (DIEA), decreased 
reaction time and higher temperature which to our satisfaction gave a enatiomerically 
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pure cis-5.22. Finally the same reaction sequence was used to prepare the other two 
stereoisomers of 5-hydroxypipecolic acid. The crystal structure of all the three, 
racemic cis-5.22,5 (R,R) cis-5.226 and (S,S) cis-5.227 were determined by single crystal 
X-ray analysis. 
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Chapter 6 
 
General Conclusion 
 
In conclusion, we have synthesized two important non-proteinogenic amino acids, 4-
hydroxy proline and 5-hydroxypipecolic acid. The strategy involved the synthesis of 
racemic amino acids which are (Boc or Ac) protected; from the commercially 
available malonate derivatives. This malonate derivatives can also be synthesized in 
laboratory using simple starting materials. The racemic amino acids (esters) with the 
side chain alkenes were efficiently resolved by enzymatic kinetic resolution. Three 
well known enzymes were tested for the resolution of the amino acids, subtilisin 
Carlsberg/-chymotrypsin were used for Boc- protected amino acid esters, whereas L-
acylase from Aspergillus genus was used for the resolution of Ac- protected amino 
acids. These enzymatic resolution selectively transformed the L- amino acids which 
were easily separated from the unchanged D- amino acids. In the case of resolution 
with L-acylase the L- amino acids were separated through DOWEX ion exchange 
resin. Whereas in the case  of resolution with subtilisin Carlsberg or -chymotrypsin 
the L amino acid was converted to an acid whereas the D- amino acid would be 
unchanged in the form of ester. So this L- acid and D-ester could be easily isolated by 
simple basic extraction follwed by recovery of the L- acid after acidification. 
In the 3 chapter we used the 2-amino-4-pentenic acid derivatives. This was easily 
obtaiined from the malonate derivatives, by alkylating with allyl bromide and 
transforming i into a racemic 2-amino-4-pentenoic acid derivative. This racemic amino 
acids resolution were tested with two enzymes L-acylase and subtilisin Carslberg. The 
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enatiomerically pure amino acids derivatives were epoxidized with m-CPBA, which 
generated the diastereomers due to the new chiral center at the C4 carbon. In our case 
diastereo selectivity of this reaction was very less, which almost gave equal amount of 
the diastereomers. This was followed by N-Boc deprotection with the aid of acid 
which generated the free amine. This amine intramolecularly attacked the epoxide to 
generate the 4-hydroxyproline diastereomers. The cis- isomer was converted to a 
lactone which was easily separated from the unlactonized trans isomer with ease. 
similarly starting forn the D isomer two diastereomers of 4-hydpoxyproline were 
syntheisized. 
In the 4 chapter we used the 2-amino-5-hexenoic acid derivatives. This was easily 
obtained from the malonate derivatives, by alkylating with 4-bromo-1-butene and 
transforming it into a racemic 2-amino-5-hexenoic acid derivatives. This racemic 
amino acids resolution were tested with two enzymes L-acylase and subtilisin -
chymotrypsin. The enatiomerically pure amino acids derivatives were epoxidized with 
m-CPBA, which generated the diastereomers due to the new chiral center at the C5 
carbon. In our case diastereoselectivity of this reaction was nil, which gave equal 
amount of the diastereomers. The epoxide diastereomers generated were separated by 
well known Jacobsen's Hydrolytic kinetic resolution (HKR).On treating the epoxide 
diastereomers with (RR)-CoIII Salen, one of the diastereomers was selectively 
converted into a dihydroxyl compound which will be sparted from the other epoxide. 
This chiraly pure epoxide, was subsequently opened with LiBr to generate the amino 
acid with bromide at the C6 carbon. This was followed by N-Boc deprotection with the 
aid of TFA which generated the free amine. This amine intramolecularly attacked the 
C6 carbon to generate the 5-hydroxypipecolic acid diastereomers. Similarly the 
dihydroxyl compound isolated earlier, was selectively tosylated at the primary 
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hydroxyl group with the aid of (cat Bu2SnO). The tosyl was replaced with an iodide to 
get  amino acid with iodide at the C6 carbon. This was followed by N-Boc deprotection 
with the aid of TFA which generated the free amine. This amine intramolecularly 
attacked the C6 carbon to generate the 5-hydroxypipecolic acid diastereomers. 
Subsequently starting from the (R)- isomer two more isomers of 5-hydroxypipecolic 
acid were synthesized, by following the same sequence described above. 
In the 5 chapter we again used the 2-amino-5-hexenoic acid derivatives. This was 
easily obtained from the malonate derivatives, by alkylating with 4-bromo-1-butene 
and transforming it into a racemic 2-amino-5-hexenoic acid derivatives. This racemic 
amino acids resolution were tested with subtilisin Carlsberg. The enatimerically pure 
amino acids derivatives were epoxidized with m-CPBA, which generated the 
diastereomers due to the new chiral center at the C5 carbon. In our case diastereo-
selectivity of this reaction was almost negligible, which gave equal amount of the 
diastereomers similar to earlier literature reports. This was followed by N-Boc 
deprotection with the aid of acid which generated the free amine. This amine 
intramolecularly attacked the epoxide to generate the 5-hydroxypipecoli acid 
diastereomers. The cis- isomer was converted to a lactone which was easily separated 
from the un-lactonized trans- isomer with ease. Similarly starting from the D isomer 
two diastereomers of 5-hydroxypipecolic acid diastereomers were synthesized. 
 To conclude, we have developed an easily scalable synthesis of 5-hydroxypipecolic 
acid and 4-hydroxyproline. Our method gives the access for all the four stereoisomers 
with ease. The cis- and trans- were isolated in a facile manner due to in-situ 
lactnization. We have used a green approach to obtain the enatiomerically pure amino 
acids. The 4-hydroxyproline and 5-hydroxypipecolic acid deivatived isolated can be 
directly applicable to solid phase peptide synthesis. 
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